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 Mesenchymal stem cells (MSCs) are multipotent cells that are recruited to sites of 
inflammation, where they interact with the microenvironment to induce tissue 
regeneration. As a result, MSCs have shown promise clinically as candidates for tissue 
engineering and therapeutic targets; however, implementation in the clinic has been 
limited by an incomplete understanding of how mechanical and chemical cues provided 
by the microenvironment influence MSC behavior. We first show how molecular cues 
change the intracellular mechanical properties of differentiating MSCs. We then 
developed 3D gelatin scaffolds for the expansion and differentiation of MSCs. We found 
that the composition of the scaffold dictated whether the mechanical or architectural 
properties directed MSC differentiation. In addition to aiding in tissue regeneration, 
MSCs are also recruited to tumors, where they interact with the tumor microenvironment 
to promote metastasis. We sought to elucidate if MSCs are differentially adherent, and 
potentially recruited more frequently, to metastatic versus nonmetastatic tumors. We 
found that MSCs are more adherent to metastatic cancer cells and this response can be 
reversed by blocking the adhesion molecule cadherin 11. Finally, we utilized a 3D 
coculture model to determine how interactions between metastatic cancer cells and MSCs 
influence cancer cell invasion. Coculture with MSCs induced directional migration in 
cancer cells that was dependent on transforming growth factor β (TGF-β) and 
downstream mechanosensitive pathways. These studies elucidate how MSCs interact 
with their environment and may have important implications in biomaterial design and 









1.1 Mesenchymal Stem Cells and Sites of Inflammation 
 Mesenchymal stem cells (MSCs) are bone marrow-derived cells that have the 
ability to differentiate into connective tissue types [1]. Natively, MSCs are mobilized 
from the bone marrow and recruited to sites of inflammation [2], including damaged 
tissue and tumors. Within these environments, MSCs have several functions, including 
differentiating into tissue-specific cell types [1], inducing angiogenesis [3], and 
modulating the immune system [4]. Tissue injury leads to immune activation and 
secretion of a number of inflammatory molecules, including platelet-derived growth 
factor (PDGF), transforming growth factor-β (TGF-β), epidermal growth factor (EGF), 
vascular endothelial growth factor (VEGF), fibroblast growth factor (FGF), and stromal 
cell-derived factor-1 (SDF-1), which induce MSC migration [5,6]. MSCs differentiate 
into myofibroblasts in response to these factors [7,8], which produce extracellular matrix 
(ECM) and contractile force to promote healing [9]. Upon completion of wound healing, 
myofibroblasts undergo apoptosis to restore normal tissue homeostasis [9]. 
 MSCs can directly interact with immune cells to alter the immune response and 
influence tissue healing. MSCs suppress inflammation by secreting TGF-β and 
prostaglandin E2, which alter the cytokine secretion profiles of dendritic cells, T cells, 
and natural killer cells [4]. Consequently, MSCs are thought to be important mediators of 
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wound healing as inflammation suppression is a critical step for proper wound healing 
[10]. In some instances MSCs promote inflammation; however, it is not understood why 
MSCs are immunosuppressive in some instances and inflammatory in other contexts [11]. 
MSCs may worsen or improve disease depending on whether MSCs display an 
inflammatory or immunosuppressive phenotype. It appears that the microenvironment 
can have profound effects on the inflammatory phenotype of MSCs [11], suggesting 
MSCs are influenced by cues from the extracellular environment. 
1.1.1 MSCs and Tissue Regeneration 
 MSCs differentiate into a number of connective tissue cell types, including 
adipocytes, osteoblasts, chondrocytes [1], and myoblasts [12]. MSCs can be isolated from 
adult bone marrow, circumventing the ethical issues associated with embryonic stem cells 
(ESCs). In addition, MSCs are immunosuppressive [4], allowing for allogenic 
transplantation. As a result of these characteristics, MSCs have shown promise for tissue 
regeneration applications. Clinical trials utilizing MSCs for the treatment of a number of 
degenerative diseases, including myocardial infarction, diabetes, spinal cord injury, graft 
versus host disease, and orthopedic injuries, are currently underway [13].  
 Successful translation of MSCs for tissue regeneration in the clinic is dependent 
on control of MSC function and differentiation. MSCs require specific chemical factors 
to differentiate along each lineage [1]. Soluble factors can also influence MSC lineage 
[14]. EGF, but not PDGF, induces MSC differentiation along the osteogenic lineage [15]. 
TGF-β enhances both myogenesis [7] and chondrogenesis [1]. MSCs also secrete a 
number of soluble factors that allow for tissue repair through angiogenesis induction, 
production of ECM, and direct differentiation (Table 1.1). 
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Table 1.1 Growth factors critical for MSC-mediated tissue regeneration [11]. 
 
Soluble Factors Role in MSC-mediated Tissue Regeneration 
EGF Wound healing, tissue regeneration 
PDGF Tissue repair 
FGF Tissue repair, cell survival and regeneration 
TGF-β Wound healing 
VEGF Angiogenesis, wound healing 




 In addition to biochemical signals, MSCs are also influenced by mechanical 
signals. Mechanical stimulation can improve differentiation along the myogenic [7] and 
osteogenic lineages [16]. The stiffness of the ECM can direct MSC lineage [17]. Stiffer 
environments are more conducive for osteogenesis, whereas MSCs differentiate along the 
adipogenic lineage in soft environments. The geometry of ECM can also influence MSC 
differentiation [18,19]. MSCs that are unable to spread differentiate along the adipogenic 
lineage [19]. In contrast, highly spread MSCs differentiate into osteoblasts [19]. Shear 
stress enhances osteogenesis [20] and endothelial differentiation [21] of MSCs. 
Mechanical signals also influence the angiogenic properties of MSCs. Mechanical 
stimulation enhances angiogenesis through FGFR1 and VEGFR signaling [22]. MSCs 
utilize adhesion molecules to attach to endothelial cells and promote blood vessel 
sprouting [23]. In addition, ECM degradation is required for MSC-mediated blood vessel 
growth [24].  
1.1.2 MSCs and Cancer 
 Tumors are thought of as wounds that do not heal, as the tumor microenvironment 
resembles wound tissue [25]. Inflammatory factors secreted by wounds are also secreted 
by tumors and facilitate the recruitment of a number of cell types that support the growth 
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of the tumor, including endothelial cells, immune cells, fibroblasts, and MSCs [26]. 
Within the tumor, MSCs contribute to angiogenesis and tumor growth through the 
secretion of IL-6 [27], CCL5 [28], SDF-1, and VEGF [29]. In addition, CCL5 secreted by 
MSCs promotes breast cancer metastasis [28]. Consequently, MSCs have been proposed 
as therapeutic targets for cancer. 
 Tumor-secreted soluble factors induce MSC differentiation into carcinoma-
associated fibroblasts (CAFs), which have a myofibroblast-like phenotype [30] and serve 
similar functions to myofibroblasts within wounds. CAFs produce and crosslink ECM, 
provide contractile force, promote angiogenesis [31], and induce inflammation [32]. It is 
hypothesized that CAFs stiffen the ECM, which promotes a malignant phenotype [33]. 
CAFs are thought to be a rate-limiting determinant for tumor progression [34], as the 
presence of a CAF gene signature is associated with poor patient prognosis [35]. Thus, 
MSCs serve similar functions in wounds [10] and tissues [29]. MSCs recruited to 
damaged tissue are involved in tissue repair allowing for tissue regeneration. In contrast, 
MSCs present in tumors promote disease progression. 
1.2 Cell Mechanics 
 Cells are exposed to a variety of biochemical and mechanical signals from the 
extracellular environment. Cells sense and respond to mechanical signals by altering their 
intracellular mechanical properties in order to resist forces. These mechanical signals can 
be transduced into biochemical signals inside the cell which ultimately regulate gene 
expression and cell phenotype. Thus, intracellular and extracellular mechanical properties 




1.2.1 Cell Adhesion, Force Generation, and Migration 
 Cells are anchored to the extracellular environment through cell adhesion 
proteins. ECM is a scaffold of proteins that provides structural stability and mechanical 
and biochemical cues critical for the formation, maintenance, and repair of tissues. These 
proteins contribute to the rigidity and viscoelasticity of tissues. In addition, ECM 
regulates the availability and activity of soluble factors. Cells dynamically remodel the 
composition, physical properties, and topography of ECM. Integrins on the cell surface 
bind to specific ligands in the ECM, such as collagen, fibronectin, and laminin. These 
receptors are involved in migration, invasion, ECM remodeling, proliferation, and 
survival [36]. 
 The actin cytoskeleton inside the cell is linked to the ECM through focal 
adhesions, which consist of transmembrane integrins that bind to matrix proteins and 
cytoplasmic proteins that link integrins to actin filaments (Figure 1.1). A number of 
cytoplasmic proteins make up focal adhesions, including focal adhesion kinase (FAK), 
paxillin, talin, vinculin, zyxin, vasodilator-stimulated phosphoprotein (VASP), and α-
actinin [37]. Focal adhesions transmit force between inside the cell and the extracellular 
environment. Interactions between myosin motors and actin generate traction forces. This 
force generation is activated by phosphorylation of myosin light chain (MLC) [38]. Rho-
kinase (ROCK) regulates the phosphorylation of MLC and is responsible for generating 
traction forces at focal adhesions [39]. Force transmission plays a critical role in many 






Figure 1.1 Diagram of the connection between the actin cytoskeleton and ECM. Actin 





Traction forces exerted by cells can be measured using traction force cytometry. This 
technique involves seeding cells on a perfectly elastic substrate with embedded particles. 
Cells pull on the matrix, displacing the beads. Cells are then detached causing the beads 
to return to their unstressed position. The displacement of the beads can be related to the 
traction stress using the following equation: 
     Displacements r G r r Traction r    
G is Green function and r is displacement. 
 Cells coordinate mechanical and biochemical signals in order to migrate. Cell 
motility is critical for the formation and organization of tissues. In addition, motility 
plays a role in a number of disease states, including wound healing, tissue regeneration, 
and metastasis. A number of coordinated steps must occur for a cell to migrate (Figure 
1.2). Cells first polymerize actin to polarize their forces and form a protrusion at the 
leading edge. This leading edge then forms adhesions to the ECM. Proteases that degrade 
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ECM are then secreted to allow space for the migrating cell. Myosin provides the force to 
contract the cell body. Finally, adhesions are turned over which allows for the cell to 








 Epithelial cells maintain cell-cell contacts and interactions with the basement 
membrane, which maintain tissue homeostasis. During development or after tissue injury, 
cells will undergo changes to a mesenchymal phenotype, known as epithelial to 
mesenchymal transition (EMT), that allow it to become more motile. Epithelial cells 
express high levels of E-cadherin, a cell-cell adhesion molecule, and ECM proteins 
laminin 1 and collagen IV [43]. During EMT, cells downregulate these proteins and gain 
expression of integrins including α5β1 integrin, the ECM protein fibronectin, and cell 
adhesion proteins N-cadherin and OB-cadherin [43]. In addition, cells reorganize their 
cytoskeleton and alter extracellular force generation after EMT [44]. This allows for cells 
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to remodel and interact with ECM in order to invade. Evidence of EMT has been 
observed at the invasive fronts of tumors [45] and in patients [46]. This suggests that 











MSCs are natively recruited to sites of inflammation, including wounds and 
tumors. The biochemical and mechanical characteristics of the microenvironment that 
MSCs interact with influences their ability to promote tissue healing or worsen disease 
state. MSCs are strong candidates for tissue engineering and therapeutic targets for 
cancer because of these characteristics. The overall goal of this project was to understand 
how MSCs interact with their microenvironment in the context of tissue regeneration and 
cancer to develop novel tissue engineering and cancer therapeutic strategies. 
We first provide an overview of intracellular particle tracking microrheology. We 
then simultaneously measured intracellular rheology and extracellular force generation to 
determine how MSCs alter forces during differentiation in environments that were 
favorable and non-conducive for differentiation. We probed intracellular and extracellular 
force generation in response to chemical differentiation factors and substrate rigidity. We 
hypothesized that MSCs would alter their intracellular rheology and extracellular force 
generation in order to differentiate and this may be an indicator of differentiation 
potential. In addition, we sought to determine if MSCs spatially regulate their 
intracellular and extracellular forces during differentiation. 
 In order to understand the effects of matrix architecture on MSC function, we 
developed cross-linked gelatin scaffolds with varying architectural and mechanical 
properties. We evaluated the proliferation and differentiation along the myogenic and 
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osteogenic lineages of MSCs cultured on scaffolds. We hypothesized that matrix 
architecture could promote the self-renewal and directed differentiation of MSCs. 
 We next sought to elucidate how MSCs engraft in tumors. We hypothesized that 
differences in cell adhesion may contribute to the differential engraftment of the CAF 
precursors fibroblasts and MSCs to invasive tumors. To test this, we analyzed the 
adhesion of fibroblasts and MSCs to invasive and non-invasive breast, ovarian, and 
prostate cancers. We then elucidated how stromal cells attach to invasive cancer cells to 
identify new targets to prevent stromal cell recruitment.  
 In order to determine how MSCs interact with invasive breast cancer cells to 
induce invasion, we utilized a 3D coculture model. We measured the migration in 
conjunction with force generation of metastatic breast cancer cells in coculture with 
MSCs. Pathways involved in MSC-induced migration were identified and inhibited, 










3.1 Introduction  
 Mechanical stress can be generated from cellular processes such as cell migration 
[48–50], stem cell differentiation [17], protein unfolding [51], and cancerous 
transformation [52]. It also plays a role in various physiological and pathological events, 
such as embryonic development [53,54], organogenesis [55], tissue regeneration [56], 
and tumor growth [57]. During these events, cells respond to the mechanical stress not 
only with simultaneous cytoplasmic deformation but also with dynamic cytoskeleton 
remodeling to continually dissipate stress. Together, how the cytoplasmic region of a cell 
responds to external forces, i.e., the intracellular rheological property, is of interest and 
essential to thoroughly understand those cellular events.  
 The molecular mechanisms for cells to dynamically regulate the intracellular 
rheological properties to respond to the physical shear stress and chemical cues from 
external environments are conserved across all cell types and species [58]. It requires the 
reorganization of the cytoskeleton, a complex network which acts as a scaffold to support 
the cell’s structure from the cell cortex to the nucleus [59]. The cytoskeleton contains 
three filamentous structures, actin (F-actin), microtubules and intermediate filaments. 
Among them, the rheological properties of actin-cytoskeleton are most well-studied. 
Intracellular mechanics have previously been related mainly to the organization of F-
actin [60,61], which controls cell shape, structure, and force generation [62]. Chemical 
                                                     
1 Adapted from: Dawson, MR, Tseng, Y, Lee, JS, & McAndrews, KM. “Intracellular 
Particle Tracking Rheology.” In: C. P. Neu & G. M. Genin (Eds.), Handbook of Imaging 
in Biological Mechanics (pp. 377–384). CRC Press, 2014. ISBN 978-1-466-58813-4 
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and physical stimuli from the extracellular environment alter cell mechanics through Rho 
GTPases, including RhoA, Rac1 and Cdc42, which act as the molecular switches to 
interact with downstream effector molecules and trigger signaling pathways to manifest 
actin cytoskeleton re-organization [18,19,63].  
 The actin-cytoskeleton contains a multitude of regulatory proteins, molecular 
motors, and actin-binding proteins (ABPs) that together mediate the organization of 
actin-cytoskeleton. The actin stress fibers link the actin-cytoskeleton to the ECM via 
focal adhesions. Motor protein myosin binds to F-actin and utilizes ATP to generate 
contraction force that propagates tension along actin filaments [64]. Distinct ABPs 
individually possess specific actin-binding activities, such as severing and elongating to 
regulate the filamentous length of actin filaments, branching, crosslinking and bundling 
to formulate the architecture of the actin network, and sequestering and nucleation to 
control the amount of available globular actin (G-actin) for filament formation in the 
cytoplasmic pool. Together, the functions and activities of motor proteins and ABPs 
provide dynamics and structural diversity to support a broad range of rheological 
properties and architecture to the actin network. 
3.2 Fluid Mechanics and Cell Rheology 
 Rheology is the study of deformation of soft matter, which is used to explain the 
mechanical behavior of complex fluids, including polymeric solutions, colloidal 
suspensions and biological gels. Complex fluids are viscoelastic in nature since they act 
as elastic solids (resisting permanent deformation) at short times and viscous fluids 
(deforming irreversibly) at longer times [65]. A rheometer is a tool to characterize the 
time- or frequency-dependent viscoelastic properties of complex fluids from the 
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mechanical deformations that result from the application of controlled stress or strain 
[66]. Bulk-fluid rheometers have previously been used to characterize the mechanical 
behavior of reconstituted solutions of cytoskeletal proteins [67]; however, these tools are 
not applicable to living cells with respect to their small size and soft cytoplasm that 
requires the application of extremely small forces (~ pN) and deformations (~ nm) [68]. 
Quantitative microscopic techniques, such as atomic force microscopy (AFM), 
micropipette aspiration, magnetic twisting cytometry (MTC), and multiple particle 
tracking microrheology (MPTM) have been developed in recent years to characterize the 
rheological properties of the cell cytoskeleton in microscopic domains for their 
rheological response during intracellular processes.  
3.3 Limitations of Current Methods for Measuring Cell Mechanics 
 Current methods for measuring cellular rheology include AFM, micropipette 





Figure 3.1 Current methods for measuring cell rheology. 
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Utilizing AFM, cell mechanical properties are determined from the deflections of a 
cantilever tip on a cell surface. AFM results depend heavily on the accuracy of the spring 
constant of the tip and the interaction of the tip with the cell surface, which in turn may 
change the mechanical properties of the cell for subsequent measurements [69]. 
Moreover, it is only capable of measuring surface properties that may reflect larger actin 
stress fibers or membrane properties. Micropipette aspiration involves deforming a cell 
by aspirating it into a micropipette and measuring the geometric changes of the whole 
cell as bulk cellular rheology. In MTC, ligand-coated magnetic beads are attached to the 
surface of the cell and magnetic pulses are applied which deform the cell. Rheological 
properties measured with MTC vary depending on the ligand chemistry and density on 
the probe beads [70], which given heterogeneous molecule expression across the cell 
could lead to results that are inconsistent or unable to be compared between experiments. 
All of the aforementioned methods are also unable to simultaneously measure multiple 
points across a cell and as such are time consuming and relatively low-throughput. In 
addition, as mechanical properties are probed from the extracellular surface, this limits 
local measurements of intracellular microrheology and analysis of cytoskeletal 
heterogeneity.  Finally, applications of AFM and micropipette aspiration are limited to 
those in which the probe can directly contact the cell and thus prevents the measurement 
of cells in three-dimensional environments or cells subjected to flow.  
3.4 Intracellular Particle Tracking Microrheology 
 In order to better assess intracellular cytoskeletal heterogeneity and avoid the 
difficulties associated with other extracellular rheological measurement methods, MPTM 
was developed [71]. MPTM can be used to determine the mechanical properties of 
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complex fluids with the accuracy of traditional bulk-fluid strain-controlled cone and plate 
rheometry [72]. MPTM can also be used to probe the local mechanical properties of 
complex fluids within microscopic domains, which is not possible with bulk-fluid 
rheological techniques. For the original approach, fluorescent submicron particles were 
microinjected into the cytoplasmic region of individual cells. This method was improved 
in efficiency by the development of ballistic intracellular particle tracking nanorheology 
to massively inject submicron particles into a million cells at once [73], thereby making it 
a powerful technique for quickly characterizing the rheological properties of samples that 
could not be achieved before.  
 Using MPTM, the displacements of the submicron particles, which result from the 
interaction between the particles and its surrounding cytoskeletal network, are used to 
determine the rheological properties of the cell cytoplasm (Figure 3.1D). It offers unique 
capacities compared to other methods for measuring the rheological properties of cells. 
Embedding particles in the cytoplasm allows for highly localized rheological 
measurements without the use of external probes [74]. Cytoplasmic viscoelasticity can be 
analyzed with this method in a variety of different conditions, including 3D culture 
[52,75], shear [73], and in vivo [76]. Moreover, the contributions of the plasma 
membrane and nucleus to the mechanical properties of the cell can be distinguished from 
cytoskeletal contributions [77].  Rheological measurements for a single cell can be 
acquired under a minute so that the short-term response of cells to specific factors can be 
analyzed [48,78]. The technique has also been used to determine the viscoelasticity of 
concentrated solutions of DNA [79], cystic fibrotic sputum [80], and actin filament 
solutions [81–84] in addition to the cell cytoplasm [48,49,73–75,77,78]. 
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 The displacements of fluorescent particles embedded in the filamentous network 
(Figure 3.2) are captured using a fluorescence microscope with high magnification and a 





Figure 3.2 Brownian motion and mean square displacements of nanoparticles embedded 
in the cytoplasm. Schematic of particle embedded in the cytoplasm (left). Example traces 
and mean square displacement (MSDs) plots of cytoplasm with viscous (top right) and 




High resolution of particle displacements is obtained by tracking the intensity weighted 
centroids of the particles in the plane of focus of the objective. Particle trajectories in the 
focal plane are 2D projections of 3D displacements, thus, 2D tracking assumes that the 
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In a purely viscous fluid, such as water or glycerol, the thermal fluctuation-driven particle 
motion is only hindered by viscous drag with the Stokes-Einstein equation: 
,
 
where D is the diffusion coefficient, kB is Boltzmann’s constant, T is temperature, a is 
particle radius, and η is viscosity of the fluid. Therefore, the particle tracking data can be 
used to extract the viscosity of the fluid surrounding the particle.  
 However, in the complex filamentous network space when the particle size is 
greater than the pore size of the meshwork, which is the distance between filaments 
aligned in any direction, particle motion is not only affected by the viscosity of the fluid 
but also the elasticity of the filamentous network. The creep compliance (Γ), which 
measures the deformability of the cytoplasm, can be directly calculated from the MSD: 
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In order to facilitate analysis of additional viscoelastic properties of the cytoplasm, the 
MSD is transferred to the frequency domain. The frequency-dependent form of the 








where G* is the frequency-dependent complex shear modulus, Γ is the gamma function 
(different from the creep compliance, Γ), α is the first derivative and β is the second 
derivative of the MSD curve. The complex shear modulus can be further divided into the 
in phase component, or elastic (storage) modulus (G’), and the out of phase component, 
or viscous (loss) modulus (G’’): 
 
 Cells behave more like an elastic solid at high frequencies, or low time scales, 
with G’ being greater than G’’. Typical values of G’ at 1 Hz are shown in Table 1. The 
shear viscosity can be estimated as the product of the plateau modulus and the relaxation 
time. The plateau modulus is the value of the elastic modulus at intermediate frequencies 
where it reaches a quasi-plateau value. Relaxation time is the inverse of frequency at 
which elastic and viscous moduli are equal. 
3.5 Intracellular Particle Tracking Microrheology Applications 
 With MPTM, the mechanical properties of the cytoplasm are determined from the 
transport patterns of hundreds of individual nanoparticle probes. Each particle probes the 
rheology of the surrounding cytoplasm, which is heavily affected by differences in the 
degree of actin crosslinking and the local microstructure. Micromechanical mapping of 
Swiss 3T3 fibroblasts revealed the cytoplasm is significantly more heterogenous than 
reconstituted actin filament networks [74]. In addition, the perinuclear region is typically 
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more compliant than the lamella [74]. Crosslinking actin with α-actinin increases the 
stiffness and heterogeneity of the cytoplasm [74], in agreement with actin solution studies 
[85]. Statistical analysis of the distributions of particles’ MSDs at specific time scales is 
used for heterogeneity analysis of the cytoplasmic region for different cell types or the 
same cell type under different treatments. Local mechanical properties from particle 
tracking analysis can also be traced back to specific regions of the cell, which can be used 
to determine how differences in cytoskeletal mechanics affect cell function. 
 Intracellular particle tracking microrheology has also been used to elucidate how 
fibroblasts spatially coordinate movement [49]. Rac1 and Cdc42 activation coordinate 
stiffening in the leading lamella and perinuclear region during migration [49]. Although 
depolymerizing microtubules has no effect on overall cell rheology, it prevents 
mechanical polarization and cell migration [49]. In addition, cancerous transformation 
potential has been associated with cytoplasmic stiffening in response to matrix 
stiffening[86], which is correlated with increased migration [87]. In contrast, treatment of 
human umbilical vein endothelial cells (HUVEC) embedded in a 3D peptide-based 
hydrogel with VEGF, which increases endothelial cell migration, decreases the elasticity 
of the cytoplasm [75]. This increase in elasticity can be reversed by inhibition of ROCK 
[75]. ROCK also plays an important role in stiffening of fibroblasts in response to flow 
[73]. Tumor conditioned media (TCM), which is a cocktail of pro-migratory factors that 
mimics factors secreted by tumors, induces stiffening and migration in both human and 
murine MSCs [48,78]. AFM, micropipette aspiration, and MPTM have been used to 
characterize the viscosity of human MSCs [78,88,89]. While AFM and micropipette 
aspiration viscosity measurements are similar, the viscosity measured with ballistic 
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intracellular particle tracking nanorheology is significantly different, presumably because 
it measures the local viscoelastisity of the cytoplasm, while the other methods mainly 
probe large stress fibers and include contributions of the nucleus and plasma membrane. 
 Cytoplasmic stiffness has been associated with metastatic potential in both breast 
cancer [90] and ovarian cancer [91]. The cytoplasm of OVCAR3 human ovarian cancer 
cells is viscoelastic, whereas OSE10 normal human ovarian epithelial cells are primarily 
viscous [92]. SKOV3 human metastatic ovarian cancer cells have a higher α value, or 
slope of the MSD curve, than both OSE10 and OVCAR3 cells (Figure 3.3B), suggesting 
less restricted particle movement in the cytoplasm. A distribution of MSDs exists in 
particles embedded in the cytoplasm of SKOV3 cells (Figure 3.3C), similar to previous 
reports with other cell lines [49,73,74,76–78,93]. The slope of the time-dependent creep 
compliance curve is higher than OSE10 and OVCAR3 cells (Figure 3.4A), indicating 
that SKOV3 have a more compliant cytoplasm in agreement with previous AFM 
measurements [91]. The viscous modulus (G’’) dominates over the elastic modulus (G’) 
at all frequencies. These results suggest the cytoskeletal network of SKOV3 is highly 









Figure 3.3 Brownian motion of nanoparticles embedded in the cytoplasm of SKOV3 
cells. Phase-contrast micrograph of SKOV3 cell ballistically-injected with 100 nm green 
particles and trace of a single particle’s motion (inset, A). Time-dependent ensemble 
average MSD of particles embedded in the cytoplasm of SKOV3 cells (B). Histogram 
showing the distribution of particle MSDs within a single SKOV3 cell for time scale τ = 






Figure 3.4 Creep compliance and viscous and elastic moduli for SKOV3 cells. Average 
creep compliance (Γ) of SKOV3 cells (A). Frequency-dependent viscous (G’, dashed 
line) and elastic (G’’, solid line) moduli of SKOV3 cells (B). Properties determined from 
ensemble-averaged MSD in Figure 1.5B. 
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3.6 Conclusions  
 Intracellular particle tracking microrheology is a powerful tool for measuring the 
mechanical properties of cells in physiologically relevant conditions. This method allows 
for the measurement of local rheological properties which cannot be measured with any 
other current method. In addition, intracellular particle tracking microrheology can be 
high-throughput and can measure changes in the intracellular rheological properties at 
multiple time scales. The corresponding changes in intracellular viscoelasity can 
elucidate a wide variety of critical cellular processes including differentiation, migration, 
cancerous transformation, and response to extracellular stimuli. Future applications for 
this technique include in vivo three-dimensional microrheology and screening of drugs 
for mechanical-related mechanisms. 




SPATIALLY COORDINATED CHANGES IN INTRACELLULAR RHEOLOGY 
AND EXTRACELLULAR FORCE EXERTION DURING MESENCHYMAL 




 The mechanical properties within the cell are regulated by the organization of the 
actin cytoskeleton, which is linked to the extracellular environment through focal 
adhesion proteins that transmit force. Chemical and mechanical stimuli alter the 
organization of cytoskeletal actin, which results in changes in cell shape, adhesion, and 
differentiation. By combining particle-tracking microrheology and traction force 
cytometry, we can monitor the mechanical properties of the actin meshwork and 
determine how changes in the intracellular network contribute to force generation. In this 
study, we investigated the effects of chemical (differentiation factors) and mechanical 
(substrate rigidity) stimuli important in MSC differentiation on the intracellular 
mechanics and traction stress generation. We found the presence of adipogenic factors 
resulted in stiffening of the actin meshwork regardless of substrate rigidity. In contrast, 
these factors increased traction stresses on hard substrates, which was associated with 
increased expression of contractility genes. Furthermore, MSCs cultured on hard 
substrates expressed both adipogenic and osteogenic markers indicative of mixed 
differentiation.  On hard substrates, heterogeneity in the local elastic modulus-traction 
stress correlation was also increased in response to adipogenic factors, indicating that 
                                                     
2 Adapted from: McAndrews, KM, McGrail, DJ, Quach, ND, & Dawson, MR. (2014). 
Spatially coordinated changes in intracellular rheology and extracellular force exertion 
during mesenchymal stem cell differentiation. Physical Biology, 11(5), 056004. 
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these mechanical properties may be reflective of differences in level of MSC 
differentiation. These results suggest intracellular rheology and traction stress generation 
are spatially regulated and contribute insight into how single cell mechanical forces 
contribute to MSC differentiation. 
4.2 Introduction 
 MSCs are adult bone marrow-derived stem cells with the ability to differentiate 
into connective tissues, including adipocytes and osteoblasts [1]. MSCs are ideal for 
tissue engineering applications due to their multipotency and immunosuppressive 
characteristics [4]; however, an incomplete understanding of how microenvironmental 
factors collectively direct stem cell fate hinders their therapeutic potential. Current 
techniques, such as histological staining and transcriptional analysis, measure the overall 
rate of MSC differentiation, not local differences in differentiating cells. A holistic 
understanding of how the microenvironment, including soluble factors and mechanical 
cues, directs stem cell differentiation on a cellular level is critical for clinical translation 
of MSC-based therapeutics. 
 Early MSC differentiation studies utilized a cocktail of soluble factors to induce 
differentiation on tissue culture plastic [1]; however, further studies demonstrated that 
biophysical factors such as matrix rigidity [17], cell shape [19], and geometric cues [18] 
also influence differentiation. In addition, mechanical cues, including intracellular and 
extracellular mechanics, can influence the effects of soluble factor cues from growth 
factors and cytokines [14]. This led to probing of intracellular mechanical properties 
[88,94,95] and traction force generation [96–98] and forecasting of stem cell fate based 
on actin cytoskeleton organization [63]. 
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 During the differentiation process, MSCs rearrange their cytoskeleton [63,99] 
which leads to changes in intracellular mechanical properties [95] and traction force 
generation [98]. Traditional intracellular mechanical characterization techniques, such as 
AFM, typically do not allow for simultaneous measurement of traction forces; 
consequently, the connection between intracellular and extracellular forces is not 
completely understood. MPTM, which involves tracking the motion of hundreds of 
individual particles embedded in the cell cytoplasm, can be used to rapidly probe the 
local and bulk rheological properties of the cell cytoplasm to determine mechanical 
properties in a high-content and spatial manner [92]. Cells ballistically injected with 
nanoparticles can be cultured on elastic substrates for simultaneous measurement of 
intracellular rheology and cell traction stress.  
 In this study, we combined MPTM and traction force microscopy to gain further 
insight into the mechanical properties and force generation of MSCs undergoing 
differentiation. Human MSCs were cultured on soft (~2 kPa) and hard (~8 kPa) substrates 
in the presence of control, adipogenic, osteogenic, and mixed differentiation media. We 
monitored local intracellular rheological properties and traction stress simultaneously and 
found MSCs increase the elastic character of their cytoplasm in response to adipogenic 
factors. On soft substrates, which were conducive for adipogenesis, cells did not alter 
traction stresses in response to differentiation factors; however, on hard substrates 
traction stresses increased in cells cultured with adipogenic factors. This increase in 
traction stresses was associated with an increase in heterogeneity in the correlation 
between local intracellular rheology and local traction stress as well as decreased 
adipogenesis.  The percentage of areas in the cell with highly elastic cytoplasm and high 
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local traction stress also increased, suggesting cells spatially regulate cytoplasmic elastic 
modulus and traction stress in response to these factors. Gene expression analysis 
revealed MLCK and MYH9 were both upregulated, which is potential mechanism by 
which these cells increase traction stresses. This study establishes that MSCs spatially 
alter cytoplasmic rheology and traction stresses during differentiation. 
4.3 Results 
4.3.1 Differentiation Capacity of MSCs in Response to Mechanical and Chemical 
Factors 
 In order to analyze the ability of MSCs to differentiate along the adipogenic and 
osteogenic lineage, qRT-PCR and histological staining were performed after 3 and 5 
weeks of culture, respectively. As previously observed [98], cells cultured in mixed 
differentiation media (MDM) displayed higher expression of adipsin on soft substrates 
(Figure 4.1A) and higher expression of osteocalcin on hard substrates (Figure 4.1B) 
though adipsin and osteocalcin expression in MDM were approximately equal to the 
negative control on glass and soft substrates, respectively. Though osteocalcin expression 
was higher for MSCs cultured in MDM on the hard substrate (8 kPa), this intermediate 
rigidity resulted in mixed differentiation into osteoblasts and adipocytes. These results 
were confirmed by histology with enhanced Oil Red O coverage on soft substrates 
(Figure 4.1C) and increased Alizarin Red on hard substrates (Figure 4.1D). These 
results suggest that in the presence of mixed chemical cues, the rigidity of the 







Figure 4.1 Differentiation capacity of MSCs cultured in different rigidity environments. 
mRNA expression analysis of adipogenic (A) and osteogenic (B) markers. GAPDH was 
used as an endogenous control and all data was normalized to the glass CM condition. 





4.3.2 Adipogenic Factors Increase Elastic Character of MSCs 
 MPTM was used to determine the local and bulk rheological properties of the 
cytoplasm for cells cultured in control or differentiation media on substrates early in the 
differentiation process (1 week). The use of MPTM allowed for the simultaneous 
measurement of intracellular rheological properties and traction stresses (Figure 4.2A). 
Substrate rigidity had no effect on the bulk rheological properties determined from the 





Figure 4.2 Microrheological characterization of MSCs undergoing differentiation on soft 
and hard substrates. Rheological properties and traction stresses of MSCs on substrates 
were simultaneously measured (A). Frequency-dependent elastic (G’, open circles) and 
viscous (G’’, open squares) moduli of differentiating MSCs (B). Viscoelastic character 









The presence of adipogenic factors in either adipogenic media (AM) or MDM increased 
the elastic modulus (G’) on both soft and hard substrates (Figure 4.3A). Differentiation 
and mechanical factors had less of an effect on the viscous modulus (G’’, Figure 4.3B). 
To further characterize the viscous and elastic properties of the cytoplasm, the phase 
angle δ was calculated with δ = 90° for a liquid and δ = 0° for a solid. The MSC 
cytoplasm was primarily viscous for all conditions, as indicated by phase angles much 
larger than 45°. The phase angle was not altered by OM, indicating that osteogenic 
factors had no effect on the bulk mechanical properties within the range of substrate 
rigidities used in this study. AM and MDM significantly (p<0.01) decreased the phase 
angle in both soft and hard environments, suggesting that adipogenic factors were 





Figure 4.3 Rheological properties of MSCs differentiating on soft and hard substrates. 
Elastic (G’, A) and viscous (G’’, B) moduli of the cytoplasm of MSCs cultured on 




4.3.3 Stiffer Environments Lead to Altered Force Profiles in Response to Adipogenic 
Factors 
 Traction force cytometry was used to determine the traction stress profiles of 
differentiating MSCs. Traction stresses are affected by two main factors: substrate 
30 
 
elasticity, and matrix displacement. Traction stresses were independent of media 
composition on soft substrates where the mean traction stress was ~500 Pa for all 
conditions (Figure 4.4A). In agreement with previous studies [100], the traction stress on 
hard substrates was increased approximately 2-fold in control conditions and up to 5-fold 
when adipogenic factors were present.  Analysis of the displacements on each substrate 
revealed that cells in AM and MDM maintained the same matrix displacements on soft 
and hard substrates, whereas displacements decreased for CM and OM (Figure 4.4B). 
Cells in CM and OM had similar traction stress profiles and displacements, suggesting 




Figure 4.4 Traction stresses exerted by differentiating MSCs on soft and hard substrates. 
Quantification of log mean traction stress (A) and bead displacement (B) of cells cultured 
on different rigidity substrates in the presence of CM, AM, OM, or MDM. ** and *** 




4.3.4 Adipogenic and Mixed Differentiation Media Lead to Shifts in Rheology-
Traction Stress Spatial Regulation in Hard Environments 
 In order to determine how local rheological properties are related to local traction 
stresses, the spatial relationship between these two properties was evaluated. For these 
calculations, the rheological properties of the cytosol surrounding a single particle were 
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calculated and related to the traction stress exerted on the substrate below that point 





Figure 4.5 Spatial analysis of elastic modulus of the cytoplasm and traction stress. 
Contour maps of traction stress (TS) overlaid with local elastic modulus (G’) surrounding 





 Cells in AM and MDM on both rigidity substrates displayed an increased number 
of particles with high elastic modulus (G’). In addition, this number appeared to be 
further increased on hard substrates with AM and MDM. Particles associated with high 
G’ also appeared to be colocalized with areas of high traction stress; therefore, spatial 
analysis of these two properties was performed to quantify this observation. On soft 
substrates, spatial regulation of traction stress and elastic modulus was relatively 
unaffected by differentiation media. The local elastic and viscous (G’’) moduli and local 
traction stress of cells in CM or OM on hard substrates clustered around a low 
normalized traction force value and similar elastic modulus; however, the presence of 
adipogenic factors in AM and MDM introduced a large degree of heterogeneity in this 





Figure 4.6 Correlation of traction stress with microrheological properties. Correlation of 
local elastic (G’) and viscous (G’’) modulus with local normalized traction force (B, n is 
number of particles analyzed. Soft CM: n=2389, Soft AM: n=3537, Soft OM: n=2031, 
Soft MDM: n=1889, Hard CM: n=3923, Hard AM: n=3830, Hard OM: n=4125, Hard 



















In addition, the percentage of particles with a corresponding high traction stress increased 
for cells in AM and MDM on hard, with approximately a 5-fold increase of particles with 
high G’ and high traction stress and a 2.5-fold increase in particles with low G’ and high 
traction stress. A similar trend was found between traction stress and G’’. 
4.3.5 Increased Forces in Response to Adipogenic Factors are Associated with 
Increased Contractility Gene but not Adhesion Protein Expression 
 Cells exert forces through sites of adhesion; consequently, increased adhesion 
protein expression may lead to increased traction stresses. In order to determine if 
enhanced traction stresses exerted by cells was a result of increased adhesion protein 
expression, cells were stained for F-actin and vinculin and imaged using confocal 
microscopy. F-actin and vinculin distribution were similar across substrate rigidity and 
media conditions (Figure 4.7A). Quantification of the ratio of vinculin to F-actin [48] 
revealed vinculin expression was not upregulated in AM and MDM on stiff substrates 
(Figure 4.7B), suggesting the increase in traction force is not a result of increased 
adhesion.  
 Focal adhesion proteins connect the extracellular environment to the actin 
cytoskeleton, which mediates force generation through actin myosin contraction. 
Changes in contractility genes may lead to increased traction stress; therefore, we 
evaluated gene expression of MLCK, MYH9, and MYL9. On soft substrates, contractility 
genes were either downregulated or unchanged in MDM compared to CM; however, on 







Figure 4.7 Analysis of mechanisms for traction stress generation. Maximum intensity 
projection immunofluorescent images of hMSCs stained for F-actin (red), vinculin 
(green), and nuclei (blue) (A). Images were used to calculate the vinculin to actin ratio 
and normalized to Soft CM condition (B). Gene expression compared to CM of MLCK, 















 In this study, we simultaneously characterized changes in intracellular rheology 
and traction force generation during MSC differentiation on soft (~2 kPa) and hard 
substrates (~8 kPa). High rigidity environments are typically more conducive for 
osteogenesis, whereas low rigidity environments favor adipogenesis; however, high 
rigidity environments inhibit adipogenesis to a greater degree than low rigidity 
environments inhibit osteogenesis [98]. As a result, lower rigidity substrates were 
selected to allow for differentiation along both lineages. Initially, the cytoplasm was 
primarily viscous; however, the elastic character increased with exposure to adipogenic 
factors. MPTM has previously been utilized to show that undifferentiated ESCs, induced 
pluripotent stem cells (iPSCs) [93], and MSCs [48,78]  have cytoplasms that are 
primarily viscous. In ESCs and iPSCs intracellular stiffening was also associated with the 
degree of stem cell differentiation [93,101]. A similar trend is present when comparing 
the cytoplasm of C. elegans embryos to that of more differentiated cells [48,78,93]. The 
cytoplasm of MSCs in AM and MDM had increased elastic character, suggesting this 
intracellular stiffening response during stem cell differentiation may be conserved in 
adipogenesis and may be critical for adipogenesis to occur. In addition, unspread cells are 
more likely to become adipocytes, whereas more spread cells are more likely to 
differentiate along the osteogenic lineage [19]. The actin cytoskeleton is a regulator of 
cell shape; thus, its ability to rearrange and alter its rheological properties may be critical 
for cell shape changes necessary for differentiation. The elastic character could also be a 
potential marker for MSC differentiation. Compared to traditional methods, MPTM can 
be performed without fixing or lysing cells which would allow for screening of 
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differentiation in live cells. In addition, changes in the cytoplasm were detected at 1 
week, whereas traditional differentiation analysis techniques such as PCR and staining 
cannot detect differences until much later in the differentiation process (approximately 3-
5 weeks). 
 We recognize that this intracellular stiffening response seems to contradict 
previous findings with AFM, which showed that adipocytes have lower elasticities than 
MSCs and osteoblasts [88]. However, this discrepancy may be a result of inherent 
differences in mechanical characterization techniques because AFM typically probes 
large stress fibers [69], whereas MPTM probes much smaller actin filaments on the order 
of nanometers [102] that are not accessible via AFM. Thus, particles embedded in cells 
for MPTM interact with smaller actin meshworks in the cell body, whereas AFM tips 
interact with significantly stiffer stress fibers in the cell cortex [77]. Since fully 
differentiated adipocytes lose their larger stress fibers [103], mechanical properties 
probed by MPTM may be more relevant for these more differentiated cells. In addition, 
decreased stress fiber formation has been associated with increased elastic moduli in 
cancer cells [52] and in MSCs treated with tumor-conditioned media [48]. Thus, the 
adipogenic process may lead to loss of stress fibers in favor of a more confined actin 
meshwork that has previously not been detected using other mechanical characterization 
techniques. 
 The rheological properties of cells were relatively unaffected by the presence of 
OM (Figure 4.2, 4.3). MSCs and osteoblasts have previously been shown in one study to 
have similar mechanical properties as measured by AFM [88]; however, there is not a 
clear consensus as to whether MSCs differentiating along the osteogenic lineage are 
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stiffer or softer than their undifferentiated counterparts [88,94,104]. Osteogenic 
differentiation is typically characterized by loss of thin parallel filaments and gain of a 
few actin filament bundles at the periphery of the cell [99]. MPTM cannot probe thick 
actin filaments [77] so these changes in cytoplasmic rheology may not be detected, but 
our results do demonstrate that the actin microstructure is unchanged during osteogenesis. 
Contrary to previous studies performed on microposts conducive for osteogenesis [98], 
OM also did not alter the traction stresses exerted by MSCs (Figure 4.4). Osteogenesis is 
typically favored in stiff environments [17,97]; consequently, MSCs may alter their 
rheological and traction profiles outside of the rigidity range studied here. 
 A relatively modest increase in substrate rigidity (~2 kPa to 8 kPa) led to dramatic 
traction stress exertion differences. Though traction stresses were increased in cells 
cultured in AM and MDM on hard substrates, on soft substrates, which were more 
conducive for adipogenesis (Figure 4.1), traction stress was independent of media 
composition (Figure 4.4A). Previous studies have demonstrated that MSCs undergoing 
differentiation on micropatterned substrates conducive for adipogenesis do not 
significantly alter their traction stresses [98].  Inhibition of cell contractility, which can 
regulate traction stresses, in MSCs cultured with mixed differentiation factors in 
significantly stiffer glass environments induces adipogenesis [19]. Moreover, in stiffer 
environments, which are more conducive for osteogenesis, traction stresses are increased. 
Consequently, inhibiting the high traction stresses generated in less favorable (stiffer) 
environments in the presence of adipogenic factors may enhance differentiation along the 
adipogenic lineage by reducing the energy barrier. Previous studies have demonstrated 
that enhanced mitochondrial respiration is required for adipogenesis [105]; therefore, 
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ATP required for cell contractility purposes would not be available for mitochondrial 
respiration. Taken together, these results could imply that alteration of traction forces in 
non-conducive mechanical environments may prevent MSC differentiation along the 
adipogenic lineage, offering further insight into how matrix stiffness directs cell lineage.  
 Deformation of the substrate decreased with increasing substrate rigidity for cells 
in CM, in agreement with studies with fibroblasts [106]. The presence of adipogenic 
factors on hard substrates was associated with increased levels of substrate deformation 
similar to substrate deformations caused by cells on soft substrates (Figure 4.4B). In 
addition, these factors were associated with an increase in actomyosin contractility gene 
expression on hard substrates (Figure 4.7). Previous studies have shown cell stiffness 
measured by magnetic twisting cytometry increases in order to balance tensile stress 
[107]; however, how local cytoplasmic stiffness changes with local traction stresses has 
not been elucidated. In agreement with average rheological properties measured (Figure 
4.2), cells cultured in AM and MDM displayed increased numbers of areas with high 
cytoplasmic elastic modulus (G’, Figure 4.5). This response was amplified on hard 
substrates and was associated with high traction stresses (Figure 4.5), suggesting high 
local G’ may be associated with high traction stress. Spatial analysis revealed adipogenic 
factors increase the percentage of areas with high G’ with corresponding high local 
traction stresses (Figure 4.6). Moreover, AM and MDM induced approximately a 5-fold 
increase the percentage of particles with surrounding high elasticity and viscosity 
cytoplasm and high local traction stress. This suggests that the cell increases the number 
of areas with spatially regulated cytoplasmic rheological properties and traction stress in 
response to adipogenic factors. The elastic and viscous character of the cytoplasm is 
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simultaneously spatially altered with traction force in response to AM and MDM. The 
elasticity and viscosity of the cytoplasm concurrently changing has been documented 
previously in MSCs treated with TCM [48,78], endothelial cells treated with VEGF [75], 
and in model actin solutions [81,108]. Greater increases in average G’ than G’’ occurred 
in response to AM and MDM compared to CM and OM (Figure 4.3), phase angle was 
calculated (Figure 4.2C) and decreased in these conditions, suggesting changes in the 
elastic modulus are dominating this response. In addition, the percentage of particles with 
low elastic and viscous moduli and low traction stress decreased in AM and MDM 
compared to CM and OM for both substrate rigidities. This may reflect a mechanical 
signature of MSCs undergoing adipogenesis and could potentially be used as a 
subcellular marker for differentiation. Increases in cell stiffness in response to increasing 
tensile stress has been attributed to myosin-based contractile machinery activation [107]. 
Expression of MLCK and MYH9 were upregulated in cells cultured on hard substrates in 
MDM, suggesting that myosin may also play a critical role in mechanotransduction in 
MSCs differentiating on hard substrates. 
4.5 Conclusions 
 In conclusion, we simultaneously measured the local intracellular rheological 
properties and traction stress generation of MSCs undergoing differentiation on soft and 
hard substrates. The cytoplasm of MSCs cultured with adipogenic factors was more 
elastic independent of substrate rigidity. However, these factors only induced increases in 
traction stresses on hard substrates, which was associated with increased expression of 
contractility-related genes and decreased differentiation, suggesting force generation is 
critical for directing differentiation. Increased heterogeneity was present in the 
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correlation between rheological properties and traction stress for MSCs cultured on hard 
substrates with adipogenic factors. In addition, there was an increase in percentage of 
areas in the cell with highly elastic cytoplasm and high local traction stress, suggesting 
local cytoplasmic rheology and traction stress are spatially regulated during 
differentiation. These results may have important implications for detecting single cell 
differentiation important in regenerative medicine applications. 
4.6 Materials and Methods 
4.6.1 Cell Culture 
 Human MSCs isolated from a 22 year old healthy male donor (Donor 7071L) 
were obtained from Texas A&M Institute for Regenerative Medicine and cultured in 
αMEM (Corning) with 20% FBS (Atlanta Biologicals), 1% penicillin-streptomycin 
(Corning), and 1% L-glutamine (Corning). For differentiation assays, control media 
(CM) consisted of αMEM with 10% FBS, 1% penicillin-streptomycin, and 1% L-
glutamine. Cells were seeded at a density of 25,000 cells/cm2 in order to allow for 
differentiation along the adipogenic lineage [19]. Adipogenic media (AM) was CM 
supplemented with 10 μg/mL human insulin, 0.5 μM dexamethasone, 0.5 μM 
isobutylmethylxanthine, and 50 μM indomethacin [109]. Osteogenic media (OM) was 
CM with 10 nM dexamethasone, 50 μM ascorbate-2-phosphate, and 20 mM β-
glycerolphosphate (Sigma Aldrich) added [109]. Mixed differentiation media (MDM) 
was created by mixing AM and OM at a 1:1 ratio. Media was replaced every 3 days for 





4.6.2 Substrate Synthesis 
 Polyacrylamide substrates were synthesized for cell analysis as previously 
described[110]. Two different rigidity substrates were fabricated: soft with 8% 
acrylamide (Sigma Aldrich) and 0.02% bis-acrylamide (~2 kPa, GE Healthcare Life 
Sciences) and hard (8% acrylamide and 0.06% bis-acrylamide, ~8 kPa). Briefly, glass 
coverslips were activated by incubation in 1% 3-aminopropyltriethoxysilane followed by 
0.5% glutaraldehyde. Acrylamide solutions were made with 200 nm red particles 
(Invitrogen) and ammonium persulfate and tetramethylethylenediamine were added to 
initiate gel polymerization. This solution was then added to glass slides and an activated 
coverslip added on top. In order to allow for cell adherence, the surface was activated 
with 0.2 mg/mL sulfosuccinimidyl-6-(4’-azido-2’-nitrophenylamino)-hexanoate (G-
Biosciences) and coated with 0.2 mg/mL rat tail collagen I (Corning), which has 
previously been shown to play a critical role in MSC differentiation [111], overnight at 
4˚C with agitation. Substrates were sterilized under UV light and incubated in media for 
at least an hour before use. Mechanical properties of the substrates were assessed via 
compression testing using a Bose Endura TEC ELF 3200 Uniaxial Testing System (data 
not shown). The Young’s modulus was calculated from the slope of the linear region of 
the stress vs. strain curve at less than 10% strain. 
4.6.3 Gene Expression Analysis 
 mRNA was isolated from hMSCs using Ribozol reagent (Amresco) and its quality 
confirmed using spectrophotometry. cDNA was reverse transcribed from mRNA using 
iScript cDNA synthesis kit (BioRad). PrimerBLAST was used to design primers for 
osteogenic and adipogenic differentiation (Table 4.1). In order to quantify gene 
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expression, SsoAdvanced SYBR Green Supermix (BioRad) was used along with primers 
to amplify target sequences in a Step One Plus thermocycler (Applied Biosystems). Gene 
expression was determined using a comparative CT method [112] with GAPDH as an 
endogeneous control for all experiments. Data is relative to the glass CM condition for 
analysis of differentiation genes. For contractility gene analysis, data is reported as gene 
expression relative to CM for the corresponding substrate rigidity. 
 
 
Table 4.1 Primers used for quantitative real-time PCR (qRT-PCR) for cells 
differentiating on substrates. 
 
Gene  Primer Sequence Accession Number 
GAPDH Forward 5’ GAAGGTGAAGGTCGGAGTC NM 002046 
 Reverse 5’ GAAGATGGTGATGGGATTTC  
Osteocalcin Forward 5’ GGCAGCGAGGTAGTGAAGAG NM 001199662 
 Reverse 5’ CTGGAGAGGAGCAGAACTGG  
Adipsin Forward 5’ GGTCACCCAAGCAACAAAGT NM 001928 
 Reverse 5’ CTACAAGCACCCACCTCCAT  
MLCK Forward 5’ CGGAGGGAGTGGAGTACATC NM 053025 
 Reverse 5’ CACAAATTCTGGGGTGCCAA  
MYH9 Forward 5’ AGGACCAGAACTGCAAGCTG NM 002473 
 Reverse 5’ GCGCTCTTCCAAGTCAGTGA  
MYL9 Forward 5’ AAAGGCGTTGCGAATCACAT NM 006097 
 Reverse 5’ ACCCCACAGACGAATACCTG  
 
 
4.6.4 Differentiation Staining 
 After 5 weeks in differentiation media, cells were fixed in formalin and stained 
for either lipid droplets using 1.5% Oil Red O (Sigma Aldrich) or calcium deposits using 
1% Alizarin Red (Sigma Aldrich) [78]. Images of fat droplets were taken using a Nikon 
Eclipse TS100 Inverted Microscope. A segmentation algorithm in MATLAB 
(Mathworks) was used to determine the area covered by Oil Red O. Alizarin Red was 




4.6.5 Microrheological Characterization 
 MPTM was used to determine the cytoplasmic rheological properties of hMSCs 
undergoing differentiation as described [78]. Previous studies have demonstrated that 
traction force [98] and intracellular mechanical properties [94] are altered after 1 week in 
differentiation media; hence, cells were analyzed after 1 week in differentiation media in 
order to evaluate cytoskeletal changes before traditional techniques (i.e. qRT-PCR and 
staining) can detect differentiation. Human MSCs were ballistically injected with 200 nm 
green fluorescent particles (Invitrogen), allowed to recover, and then seeded on 
polyacrylamide substrates. After one week in differentiation media, videos of particle 
motion were taken using a Nikon Eclipse Ti inverted microscope equipped with a 
Photometrics QuantEM CCD camera. Imaging was performed with a 40x oil immersion 
lens with 1.5x zoom. The x-y coordinates where each video was taken were saved for 
traction force analysis. An average of 15 cells with 10-20 particles per cell was analyzed 
per experiment. Particle traces were created by applying a bandpass filter, determining 
the centroid of the particle as described [114], and the trajectories linked using a 
Hungarian linker algorithm. MSDs of particles were determined using a previously 
described custom MATLAB algorithm [78] and the following equation: <Δr2(τ)> = 
<[x(t+τ)-x(t)]2+[y(t+τ)-y(t)]2>. Cytoplasmic fluid is locally isotropic [115]; therefore, it is 
sufficient to track displacements in the x and y directions to estimate the 3D projection. 
The MSDs were then related to the frequency-dependent complex shear modulus (G*) 




kB is Boltzmann’s constant, T is temperature (37˚C), a is the particle size, Γ is the gamma 
function, α is the first derivative and β is the second derivative of the MSD curve. The 
elastic (G’) and viscous (G’’) moduli are the imaginary and real components of G*, 
respectively. Phase angle was calculated using the following equation: δ=arctan(G’’/G’), 
where δ=0˚ is an elastic solid and δ=90˚ is a viscous liquid. 
4.6.6 Traction Force Microscopy 
 After particle tracking videos were collected, images of the cells and stressed gels 
were taken. Cells were then lysed with 0.5% SDS (BioRad) and an image of the 
unstressed gel was obtained. In addition, an image of the stationary bottom of the gel was 
taken before and after detachment to correct for drift. An average of 15 cells was 
analyzed per experiment. A custom-written MATLAB algorithm was then used to 
determine the cell-generated displacement field and calculate traction forces [116]. 
4.6.7 Rheology-Traction Force Correlation Analysis 
 Local rheological properties were correlated with local traction stresses using a 
custom-written MATLAB algorithm. After MPTM and traction stress analysis, the mean 
traction stress for a 3-pixel dilation around each particle location was calculated. This 
calculated mean local traction stress was normalized to the mean traction stress of all 
conditions of the same substrate rigidity and correlated with the elastic (G’) and viscous 





















4.6.8 Immunofluorescence Staining and Analysis 
 MSCs cultured in differentiation media for 1 week were fixed in formalin, 
permeabilized with Triton X-100 (BioRad), blocked with serum, and stained for F-actin 
and vinculin using rhodamine phalloidin (Invitrogen) and rabbit anti-vinculin 
(Invitrogen) followed by goat anti-rabbit Alexa Fluor 488 (Invitrogen). Imaging was 
performed with a Zeiss LSM 700 confocal microscope at 40x magnification.   
4.6.9 Statistical Analysis 
 Gene expression and staining experiments were performed in triplicate. For 
MPTM and traction force analysis, 4-6 experiments were performed. A student’s t-test 
was used for all statistical analysis with p<0.05 being statistically significant (* p<0.05, 
** p<0.01, *** p<0.001). Data were reported as the mean ± standard error of the mean 





ARCHITECTURAL AND MECHANICAL CUES DIRECT MESENCHYMAL 




 Naturally-derived biomaterials have emerged as modulators of cell function and 
tissue substitutes. Here, we developed cross-linked glutaraldehyde scaffolds for the 
expansion and differentiation of MSCs. The mechanical and architectural properties of 
the scaffolds were altered by varying the concentration of gelatin and glutaraldehyde.  
Higher glutaraldehyde concentrations were associated with an increase in more confined 
pores and osteogenic differentiation. In addition, myogenic potential varied with 
crosslinking degree, although bulk mechanical properties were unaltered. Correlational 
analysis revealed alkaline phosphatase (ALP) activity of differentiated MSCs on higher 
gelatin concentration scaffolds was dependent on traditional effectors, including 
environment elasticity and spread area. In contrast, the differentiation capacity of cells 
cultured on lower gelatin concentration scaffolds did not correlate with these factors, 
instead were dependent on the hydrated pore structure. These results suggest scaffold 
composition can determine what factors direct differentiation and may have critical 
implications for biomaterial design. 
 
 
                                                     
3 Adapted from: McAndrews, KM, Kim, MJ, Lam, TY, McGrail, DJ, & Dawson, MR. 
(2014). Architectural and Mechanical Cues Direct Mesenchymal Stem Cell Interactions 




 The ability to transplant organs and tissues has saved many lives and 
revolutionized the field of medicine; however, limitations in available donor organs and 
tissues, high costs associated with transport surgeries, and poor compliance with life-time 
regimens of immunosuppressive drugs reduce the number of patients that can benefit 
from this therapy. Tissue engineering provides an alternative source to obtain tissues and 
organs that can be used to replace or regenerate tissues damaged by disease, congenital 
abnormalities, or traumatic injury. Naturally derived polymers, including collagen and 
gelatin, have been proposed as potential tissue substitutes because they are non-
immunogenic, biocompatible and biodegradable. Gelatin, which is denatured collagen, is 
a relatively inexpensive FDA approved biomaterial that has been utilized in a variety of 
applications [117–119]; however, its applicability in the clinic is limited by its poor 
mechanical strength. Glutaraldehyde (GTA) has been used as a cross-linker to enhance 
the mechanical properties of collagen-based scaffolds [120] because of its low cost and 
ease of availability. In addition, glutaraldehyde has been used clinically in prosthetic 
implants. Although glutaraldehyde can be toxic to cells, it can be neutralized by lysine 
[121].  
 The addition of cells to a regenerative biomaterial can further enhance the healing 
process. MSCs are multipotent adult bone marrow-derived stem cells that can 
differentiate into various connective tissues, including bone, fat, and cartilage [1]. MSCs 
have shown promise for tissue regeneration applications because they are easily 
accessible, are immunosuppressive [4] and do not undergo tumorigenesis in vivo [122] 
and have been used for a variety of applications clinically, including liver disease [123], 
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subcutaneous wounds [124], and osteogenesis imperfect [125]. The implementation of 
MSCs in the clinic has been limited by low implanted cell survival rates [126] and an 
incomplete understanding of how MSC differentiation is affected by the 
microenvironment [127]. Biomaterials can affect cell proliferation, differentiation, ECM 
secretion and remodeling, and formation of functional tissues; thus, they have shown 
promise for directing cell function [128] and MSC differentiation [96,97,129]. Numerous 
studies have highlighted the effects of physical and chemical cues from the tissue 
microenvironment on MSC differentiation [17–19,97], though the role of the 3D 
architecture has not been fully elucidated. We hypothesized that it was not just the bulk 
mechanical properties of tissue engineered scaffolds but the microscopic architecture of 
these environments that direct MSC fate.  
 In these studies, we fabricated gelatin-glutaraldehyde scaffolds and altered the 
mechanical properties (bulk elastic moduli of ~10-40 kPa) and architectural properties 
(pore size and fiber structure) by varying the concentration of gelatin and glutaraldehyde. 
Osteogenic differentiation was induced on scaffolds with relatively low amounts of 
glutaraldehyde (0.1-1.0% w/v). In addition, myogenic potential varied on scaffolds with 
similar bulk mechanical properties. We found that mechanical properties of the scaffold 
and the extent of cell spreading directly correlated with osteogenic differentiation on 10% 
(w/v) gelatin scaffolds; whereas on 5% gelatin scaffolds, the hydrated microscale pore 
structure played a stronger role in directing differentiation. These results suggest that in 
addition to matrix stiffness, cells also sense architectural properties of their local 
environment and integrate these cues when undergoing lineage commitment. By 
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elucidating the interplay of these two factors, this work seeks to improve matrix-directed 
MSC differentiation. 
5.3 Results 
5.3.1 Characterization of Gelatin-Glutaraldehyde Scaffolds 
 The Young’s moduli of 5% (w/v) gelatin (G) scaffolds were relatively constant 
(~15 kPa) across GTA concentration (Figure 5.1A). The bulk mechanical properties of 
10% G 0.1% (w/v) GTA scaffolds were similar to 5% scaffolds. Higher concentrations of 
GTA were associated with approximately 3-fold increase in bulk stiffness for 10% 
scaffolds (~50 kPa).  In order to determine the stability of the scaffolds, we measured 
protein release over time. Scaffolds with 0.1% GTA released more gelatin than those 
containing 0.5 and 1% GTA (p<0.05); however, low amounts of protein were released 
from all scaffolds, suggesting they remain intact (Figure 5.1B). All scaffolds swelled 
approximately 7- to 15-fold within one day and then remained relatively constant over a 
seven day period (Figure 5.1C). Swelling in 5% gels was relatively independent of GTA 
concentration, while in 10% gels, swelling was significantly reduced in 0.5% and 1% 
GTA concentrations compared to 0.1% GTA (p<0.01). Together these data suggest the 







Figure 5.1 Characterization of gelatin-glutaraldehyde scaffolds. The effect of scaffold 
composition on the mechanical properties (A) and degradation (B) and swelling (C) 




5.3.2 Scaffold Composition Alters Pore Architecture 
 In order to analyze the architecture of the scaffolds, we imaged the scaffolds using 
scanning electron microscopy and quantified pore size. Average pore size was similar for 
5% G 0.1% GTA and 5% G 0.5% GTA scaffolds (30-40 μm2). The 10% G 0.1% GTA 
scaffold had the largest average pore size (100 μm2). In addition, 10% G scaffolds had 
larger fibers than 5% G scaffolds. The highest GTA concentration was associated with a 
smaller pore size. For 1% GTA concentrations, average pore size was independent of 
gelatin concentration; however, the variation was higher in 10% scaffolds, suggesting a 







Figure 5.2 Effect of scaffold composition on pore architecture. Pore sizes were 
quantified from scanning electron microscopy images (A). Pore size was relatively 
constant cross glutaraldehyde concentration for 5% gelatin scaffolds and decreased for 
10% gelatin scaffolds (B). Surface area available for cell attachment was approximately 







Although the pore size distribution varied with scaffold composition, the surface area 
available for cell attachment was relatively constant (Figure 5.2C). 
5.3.3 Increasing Glutaraldehyde Concentration Leads to More Confined Pores 
 We utilized MPTM to probe the pore structure of hydrated scaffolds in cell 
culture relevant conditions. The embedded particles underwent thermal Brownian motion 
which was evaluated by tracking the x-y coordinates of the particles. Unlike scanning 
electron microscopy which has a characteristic length scale of several microns, MPTM 
has a characteristic length scale of approximately 100 nm. The extent of motion can be 
determined by calculating the MSD. MSD is time dependent for viscous fluids and time 
independent for elastic solids. MSD plots revealed all scaffolds behaved as elastic solids 
at short time scales and viscous fluids at long time scales (Figure 5.3A). Particle MSDs 
in scaffolds containing 0.1% GTA compared to higher amounts of GTA had decreased 
magnitude and increased heterogeneity in particle MSDs at τ=1s (Figure 5.3B). This 
suggests that a distribution of particle motions exists, with a portion of particles that 
displayed increased motion, whereas others did not, indicating that these particles were 
likely confined by the microstructure of the hydrated scaffold. In addition, particles in 
scaffolds with higher concentrations of GTA displayed a decreased average slope 
(anomalous diffusion coefficient, α) at long time scales than those with 0.1% GTA. 
Because α can be used to describe the relative viscoelastic character of the fluid 
surrounding particle, with α=0 characteristic of a Hookean elastic solid, α=1 
characteristic of a Newtonian viscous fluid and 0<α<1 characteristic of a viscoelastic 
fluid, we further analyzed individual particles to determine if the particles are more 







Figure 5.3 Variation in MSD and confinement of particles with changes in scaffold 
composition. Average particle MSDs (A), dot plot of individual particle MSDs at τ=1 s 
(B) and the percentage of less confined particles with α>0.5 between τ=1 s and τ=10 s (C) 










All scaffolds had a characteristic relaxation time at approximately τ=1 s; therefore we 
analyzed α from τ=1 s to τ=10 s. The percentage of less confined particles was similar for 
0.1% and 0.5% GTA concentrations independent of gelatin concentration. Cross-linking 
with 1% GTA was associated with a significant decrease in particles that were less 
confined, suggesting there is a higher percentage of smaller pores in this condition 
(Figure 5.3C). 
5.3.4 Scaffold Composition Affects Proliferation and Differentiation Potential 
 In order to determine the effect of scaffold composition on cellular function, we 
performed spreading, proliferation and differentiation assays. After 24 hours on the 
scaffolds, images of the cells were taken (Figure 5.4A). Although cell spreading 
increased with GTA concentration, the amount of gelatin did not significantly affect cell 
spreading (Figure 5.4B). At day 3 on the 5% G, there were significantly more MSCs on 
the 0.5% GTA and 1% GTA scaffolds than on the 0.1% GTA scaffold. (Figure 5.4C). A 
similar trend was found by measuring MTT absorbance, with similar viability for cells on 







Figure 5.4 Changes in MSC spreading and proliferation on scaffolds. The spreading of 
MSCs on the scaffold was quantified (B) based on phase contrast images (A). Scaffold 
composition altered the proliferation and viability of MSCs cultured on the scaffolds for 




Viability was significantly decreased on the 10% G 0.1% GTA scaffold. In addition, cells 
cultured on 5% G 1% GTA scaffolds were significantly more viable than cells on 10% G 
1% GTA scaffolds. 
 We next sought to determine how the mechanical and architectural properties of 
the scaffolds affected differentiation potential. Because MSCs have increased 
differentiation potential along the myogenic and osteogenic lineage on 2D substrates with 
elasticities similar to the scaffolds we developed [17], we performed both osteogenic and 
myogenic induction on gelatin scaffolds. Cells were differentiated along the osteogenic 
lineage on scaffolds for 3 weeks and stained for ALP activity (Figure 5.5A). Osteogenic 
differentiation was inhibited on the 10% G 0.1% GTA scaffold. Although 5% G scaffolds 
displayed similar mechanical properties, osteogenic potential varied with GTA 
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concentration (Figure 5.5B). Gross imaging of the scaffolds after 3 weeks of 
differentiation revealed enhanced mineralization in the 5% G (Figure 5.6), in agreement 
with ALP activity results. Gene expression of osteopontin and osteocalcin was increased 
in cells cultured on 5% G scaffolds with increasing GTA concentrations (Figure 5.5C). 
In addition, cells differentiated on the 10% G 1% GTA scaffold had significantly less 
ALP activity and lower expression of osteocalcin, and consequently less differentiation, 
than the 5% G 1% GTA scaffold. In order to evaluate if gelatin scaffolds enhance 
differentiation along other lineages, cells were differentiated in myogenic media. 
Myogenin and MyoD were both upregulated in cells cultured on 5% G 1% GTA 
scaffolds compared to 10% G 1% GTA scaffolds (Figure 5.5D). Similar to osteogenic 








Figure 5.5 Differentiation capacity of MSCs cultured on scaffolds. Osteogenic 
differentiation capacity of MSCs was determined by staining for ALP activity (A) and 
quantified by absorbance at 595 nm (B). Expression of genes associated with osteogenic 
(C) and myogenic differentiation (D). na: gene expression analysis not performed due to 








Figure 5.6 Mineralization of scaffolds by differentiating MSCs. Scanned images of blank 
(no cells), control media, and osteogenic media scaffolds after 3 weeks of culture reveals 





 In this study, we developed gelatin scaffolds with differing mechanical properties 
and pore sizes by altering the concentrations of gelatin and glutaraldehyde. Lysine was 
used in these studies to neutralize glutaraldehyde and circumvent glutaraldehyde toxicity 
issues. Typically hydrated gelatin scaffolds have extremely low mechanical strength 
[119] and high swelling and degradability [130], limiting their use as biomaterials; 
however, gelatin scaffolds cross-linked with glutaraldehyde displayed enhanced 
mechanical properties and stability (Figure 5.1). Notably, increasing GTA from 0.1% to 
0.5% resulted in a two-fold decrease in degradation (Figure 5.1B). Scanning electron 
microscopy images of 10% G 0.1% GTA scaffolds showed the gelatin was not 
completely cross-linked (Figure 5.2), which may be why this scaffold had a lower 
elasticity and higher swelling (Figure 5.1).  
 Although bulk mechanical properties were not dependent on GTA concentration 
for 5% G scaffolds (Figure 5.1A), pore architecture changed with additional GTA 
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(Figure 5.2). At the two higher GTA concentrations, the average pore sizes were similar 
for 5% G and 10% G gels; however, the standard deviations of the pore size distributions 
were different (Figure 5.2). These data suggest that measuring bulk or average properties 
alone may not accurately capture the properties of the material. In addition, samples were 
lyophilized for analysis which may not be representative of culture conditions. In order to 
analyze the pore structure while the scaffold is in cell culture conditions, we utilized 
MPTM. While scanning electron microscopy can probe pore structure on the order of 
several microns, MPTM probes a much smaller length scale, approximately 100 nm. All 
scaffolds behaved like elastic solids at short time scales and viscoelastic fluids at longer 
time scales (Figure 5.3A). In addition, particles encountered a heterogeneous 
microenvironment, consistent with MPTM results in other polymers [131]. The 
magnitude of the average MSD was similar for all 10% G scaffolds, but 5% G show an 
increasing magnitude with increasing GTA (Figure 5.3A). This may be a result of 
polymerization kinetics as increased cross-linker concentration [132] and polymer 
concentration [133] have been associated with increased polymerization rates. High 
amounts of polymer may lead to rapid polymerization, causing the formation of a 
network of heterogeneous fiber sizes. For lower amounts of polymer, more cross-linker is 
available, leading to the formation of small fibers. Small fibers may be destroyed during 
lyophilization and thus will not contribute to pore size measured by scanning electron 
microscopy, but will be intact for microrheological methods. We hypothesize that 
polymerization reaction of the lowest amount of gelatin (5%) and glutaraldehyde (0.1%) 
may be diffusion-limited and thus has more small pores, causing a decrease in the 
magnitude of the average MSD. While 0.1% and 0.5% GTA cross-linked scaffolds had a 
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similar percentage of particles that were less confined a larger percentage of particles in 
1% GTA scaffolds were more confined (Figure 5.3B). This trend was not present in 
freeze-dried samples for scanning electron microscopy, suggesting the pores may be 
changing shape with lyophilization.  
 Though previous studies have shown MSCs proliferate more in stiffer 
environments [134], our results suggest that stiffness alone is not predicative of MSC 
proliferation on gelatin-glutaraldehyde scaffolds (Figure 5.4C,D). In addition, matrix 
elasticity can direct MSC lineage towards cell types with similar elasticity in vivo [17]. 
MSC myogenic potential has been enhanced on 2D substrates with elasticities around 10 
kPa [17,135], similar to the elasticity of 5% G scaffolds. While myogenin expression was 
relatively constant across GTA concentrations for 5% G scaffolds, MyoD was 
significantly upregulated on 5% G 1% GTA scaffolds (Figure 5.5D), suggesting the bulk 
mechanical properties alone do not direct MSC myogenic differentiation on gelatin 
scaffolds. 
 Numerous studies have also shown that MSCs have increased propensity to 
differentiate into osteoblasts in stiffer environments [17,136]. MSCs differentiated on 5% 
G 1% GTA scaffolds had enhanced expression of osteopontin and osteocalcin (Figure 
5.5C), which are late stage osteogenesis markers, suggesting this scaffold composition 
not only enhanced differentiation, but also generated a more terminally differentiated 
cell. Interestingly, on the scaffolds MSCs did not display enhanced differentiation on 
10% G scaffolds, which had higher elastic moduli. Young’s modulus correlated with 
ALP activity for 10% G scaffolds (R2=0.99, Figure 5.7A). Pore size and osteogenic 
differentiation potential were weakly inversely correlated for both 5% G (R2=0.70) and 
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10% G scaffolds (R2=0.77) (Figure 5.7B). Increased MSC spread area has also been 
shown to promote differentiation along the osteogenic lineage [19]; however, there was 
only a correlation between spread area and ALP activity for 10% G scaffolds (R2=0.98, 
Figure 5.7C) suggesting enhanced cell spreading does not promote differentiation on 5% 
G scaffolds. The differentiation potential for 5% G scaffolds directly correlates with the 
percentage of unconfined particles (R2=0.99, Figure 5.7D), implying the effective pore 
size plays a more important role in directing differentiation than the bulk mechanical 
properties of our scaffolds and the ability of cells to spread on 5% G scaffolds. In 
addition, on the 10% G 0.1% GTA scaffold where pores were not completely formed 
(Figure 5.2), MSCs were unable to differentiate into osteoblasts (Figure 5.5B). Previous 
work has demonstrated that pore size is critical for bone reformation, which was 
attributed to enhanced MSC mineralization [137]. Other researchers have postulated that 
pore size and distribution and surface structure may play an important role in osteogenic 
differentiation [137]. Our studies demonstrate that the composition of the scaffold can 





     
 
Figure 5.7 Correlation of scaffold properties with differentiation potential. Mechanical 
properties (A), average pore size (B), spread area (C), and the percentage of less confined 
particles with α>0.5 (D) correlated differently with ALP activity for 5% (black circles) 
and 10% gelatin (grey diamonds) scaffolds. Linear fits to each data set were performed 





 In conclusion, we developed gelatin-glutaraldehyde scaffolds for the expansion 
and differentiation of MSCs. The concentration of gelatin and glutaraldehyde in the 
scaffold regulated the mechanical and architectural properties, which ultimately 
determined the differentiation potential of MSCs cultured on the scaffold. These findings 
may have important implications for scaffold design for tissue engineering applications. 
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5.6 Materials and Methods 
5.6.1 Materials 
 Gelatin was purchased from Sigma Aldrich. IMDM, L-glutamine, and penicillin-
streptomycin were purchased from Corning. Premium select FBS was purchased from 
Atlanta Biologicals (Lot L12163). Fluorosphere carboxylate-modified 200 nm red 
particles were purchased from Invitrogen. All other materials were purchased from 
VWR.  
5.6.2 Preparation of Scaffolds 
 Gelatin was dissolved in distilled water for 15 min at 70℃ under magnetic stirring 
to make 5 wt% and 10 wt% solutions. A 5% GTA solution was then added to mixtures to 
form 0.1, 0.5, and 1.0 wt% solutions. The mixture was vortexed and then cast. The 
scaffolds were refrigerated at 4°C before use. Scaffolds were lyophilized for scanning 
electron microscopy imaging and water absorption studies. 
5.6.3 Mechanical Testing 
 Gelatin scaffolds were prepared in a petri dish.  After 24 hours, scaffolds were cut 
into 3 sections and rehydrated in PBS. The Young’s modulus was measured by 
compression testing using a Bose Endura TEC ELF 3200 Uniaxial Testing System.  The 
Young’s modulus was calculated from the slope of the stress vs. strain curve in the linear 













5.6.4 Scanning Electron Microscopy Imaging 
 Lyophilized scaffolds were coated with gold for 30 seconds using gold sputter 
coater. Scaffolds were imaged using a Hitachi S800 field emission gun scanning electron 
microscope. The pore area was calculated by manually tracing the pores in ImageJ 
software (NIH). To calculate surface area, gelatin fibers were segmented in a custom-
written MATLAB algorithm after convolution with a LaPlacian of Gaussian (LoG) mask.  
5.6.5 Multiple-Particle Tracking Microrheology 
 Twenty second videos of the thermal displacements of 200 nm carboxylated 
particles embedded in the scaffold were captured using a Photometrics QuantEM CCD 
camera at 30 frames per second and a Nikon epifluorescent microscope with a TIRF 100x 
lens (Nikon) at 37˚C. The coordinates of the particles were determined and analyzed 
using a custom written MATLAB algorithm. Briefly, a bandpass filter was applied to the 
images and the centroid of the particle determined with sub-pixel accuracy as described 
[138]. Particle trajectories were determined using a Hungarian linker algorithm. The 
MSD were calculated using a previously described custom MATLAB algorithm [48,139] 
and the following equation: <MSD(τ)> = <[x(t+τ)-x(t)]2+[y(t+τ)-y(t)]2>. MSD can be 
described by a power law: <MSD(τ)> = 4Dτα, where D is the diffusion coefficient and α 
is the anomalous diffusion coefficient. The anomalous diffusion coefficient can be used 
to describe the motion of the particle, with α=0 characteristic of a Hookean solid, α=1 
characteristic of a Newtonian fluid and 0<α<1 characteristic of a viscoelastic fluid. The 
slope of the logarithmic MSD curve (α) was calculated by using finite difference between 
τ=1 s and τ=10 s. Any slope greater than one (indicative of convective transport) or less 
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than zero was automatically excluded from analysis to eliminate the effects of motion 
artifact from sample drift. 
5.6.6 Water Absorption Test 
 Lyophilized scaffolds were weighed to obtain dry weight (Wd). Cell culture 
growth media was added to the scaffold to reach saturation. Samples were incubated at 
37 ̊C to mimic culture conditions. The wet weight (Ww) of each scaffold was obtained 
after 24, 48, 72, and 96 hrs. The water absorption ability of the scaffolds was calculated 










 Phosphate buffered saline (PBS) solution was added into polymerized scaffolds 
and incubated at 37 ̊C. The supernatant was collected at 24, 48, and 72 hrs. BCA assay 
was used to determine the amount of gelatin released using a standard curve. 
5.6.8 Cell Culture 
 MSCs were isolated from 4 week old Balb/C mice (Jackson Laboratory) as 
described previously[48]. Cells were cultured in IMDM supplemented with 20% FBS, 2 
mM L-glutamine, and 100 U/mL penicillin-streptomycin. Flow cytometry was performed 
to confirm cells were Sca-1+, CD29+, CD105+, CD11b- and CD45- and osteogenic and 
adipogenic assays on tissue culture plastic were performed to confirm the MSC 
phenotype (data not shown). For all experiments, gelatin was autoclaved prior to scaffold 
formation. Uncross-linked glutaraldehyde was neutralized by multiple changes of 1% 




5.6.9 Cell Proliferation 
 MSCs were seeded on scaffolds at a density of 5,000 cells per scaffold (10,000 
cells/cm2) in order to allow space for proliferation and cultured for 3 days. The cells were 
then removed by trypsinization, resuspended in Isoton II solution, and counted using a 
Beckman Coulter Multisizer 3 Coulter Counter. Proliferation index was calculated as the 
number of cells for each condition divided by the overall average number of cells for 
each experiment. 
5.6.10 MSC Differentiation 
 For osteogenesis experiments, MSCs were cultured on scaffolds in either control 
media (IMDM, 20% FBS, 1% penicillin-streptomycin and 1% L-glutamine) or 
osteogenic media (IMDM, 20% FBS, 1% penicillin-streptomycin, 1% L-glutamine, 10 
nM dexamethasone, 20 nM β-glycerolphosphate, 50 μM ascorbate-2-phosphate, and 50 
ng/mL L-thyroxine sodium pentahydrate) as described previously [109] for 3 weeks. 
Cells were then fixed with formalin and stained for ALP expression using NBT/BCIP 
reagent. Images were taken using a Nikon SMZ745T stereoscope. ALP activity was 
determined from the absorbance at 595 nm of cells cultured in osteogenic media 
normalized by absorbance of cells cultured in control media. For myogenic 
differentiation, MSCs were cultured on scaffolds in control media supplemented with 10 
ng/mL human recombinant TGF-β1 (Biolegend) for 1 week. 
5.6.11 Gene Expression Analysis 
 RNA was isolated from MSCs cultured on scaffolds in osteogenic media for 3 
weeks or myogenic media for 1 week using Ribozol reagent (Amresco) and reverse 
transcribed to cDNA using iScript cDNA synthesis kit (BioRad). Gene expression 
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analysis was not performed on cells cultured on 10% gelatin 0.1% GTA scaffolds due to 
low cell numbers. Primers were designed using Primer3 software [140]. qRT-PCR was 
performed on the target sequences listed in Table 5.1 using SsoAdvanced SYBR Green 
Mastermix (BioRad) in a StepOne Plus Thermocycler (Applied Biosystems) for 40 
cycles. For osteogenesis experiments, data was reported after normalization to 
endogenous GAPDH and expression of cells cultured on 5% gelatin 0.1% glutaraldehyde 
scaffold. Data for myogenesis was normalized to GAPDH and Wilcoxon-Mann-Whitney 
rank sum test was used for statistical analysis. 
 
 
Table 5.1 Primers used for qRT-PCR for cells differentiating on gelatin scaffolds. 
 
Gene  Primer Sequence Accession Number 
GAPDH Forward 5’ AGGTCGGTGTGAACGGATTTG NM 008084 
 Reverse 5’ TGTAGACCATGTAGTTGAGGTCA  
ALP Forward 5’ TCAGGATGAGACTCCCAGGA NM 007431 
 Reverse 5’ GTGTGTGTGTGTGTCCTGTC  
Osteocalcin Forward 5’ CAGTATGGCTTGAAGACCGC NM 007541 
 Reverse 5’ AGAGAGAGAGGACAGGGAGG  
Osteopontin Forward 5’ GAGAGCGAGGATTCTGTGGA NM 001204201 
 Reverse 5’ CGACTGTAGGGACGATTGGA  
Myogenin Forward 5’ ACCTTCCTGTCCACCTTCAG NM 031189 
 Reverse 5’ CACCGACACAGACTTCCTCT  
MyoD Forward 5’ TGGTTCTTCACGCCCAAAAG NM 010866 




5.6.12 Statistical Analysis 
 All experiments were performed in triplicate. Unless otherwise noted, a student’s 
t-test was used for statistical analysis with p<0.05 being statistically significant (* 
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6.1 Summary 
 Cancer-associated fibroblasts (CAFs) are known to promote tumor growth and 
metastasis; however their differential accumulation in invasive and non-invasive tumors 
is not fully understood. We hypothesized that differences in cell adhesion may contribute 
to this phenomenon.  To test this, we analyzed the adhesion of CAF-precursors 
fibroblasts and MSCs to invasive and non-invasive cancers originating from the breast, 
ovaries, and prostate. In all cases stromal cells preferentially adhered to more invasive 
cancer cells. Modulating integrin and cadherin binding affinities with calcium chelation 
revealed that adhesion was independent of integrin activity but required cadherin 
function. Invasive cancer cells had increased expression of mesenchymal markers 
cadherin 2 and 11 that localized with stromal cell cadherin 11, suggesting that these 
molecules are involved in stromal cell engraftment. Blockade of cadherin 11 on stromal 
cells inhibited adhesion and may serve as a target for metastatic disease. 
6.2 Introduction 
 The progression of cancer from a benign mass of abnormal cells to a malignant 
tumor requires the development of a tumor-promoting microenvironment, which includes 
a scaffold of ECM proteins and a network of supporting cells and growth factors [26]. A 
multitude of cell types are recruited to the tumor under the influence of tumor-secreted 
                                                     
4  Adapted from: McAndrews, KM, Yi, J, McGrail, DJ, & Dawson, MR. (2015). 
Enhanced Adhesion of Stromal Cells to Invasive Cancer Cells Regulated by Cadherin 11. 
ACS Chemical Biology. doi:10.1021/acschembio.5b00353 
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growth factors and chemokines; this includes immune cells, endothelial cells, and 
fibroblasts that play an  important role in tumor growth by modulating the immune 
response, promoting angiogenesis, and forming the stroma [141]. In part to the critical 
role of the tumor microenvironment in cancer progression, drugs targeting these stromal 
cells have been increasing in demand. Several drugs that target the inflammatory signal 
COX-2 have been investigated for the treatment of cancer including rofecoxib and 
celecoxib [142]. In addition, bevacizumab, sorafenib, sunitinib, pazopanib, and 
everolimus are FDA-approved drugs that alter angiogenic activity in tumors [143]. 
Stromal fibroblasts have been specifically targeted with imatinib, sunitinib, and 
sibrotuzumab [26]. Fibroblasts and MSCs are recruited to the tumor microenvironment 
from nearby tissue and the bone marrow [144], possibly through increased migration in 
response to tumor-secreted soluble factors [48,78,145]. Within the tumor, these cells 
promote tumor growth, invasion, and angiogenesis [28,146]. Both MSCs and fibroblasts 
can differentiate into CAFs, or myofibroblasts, within the tumor. CAFs promote 
inflammation [32], tumor growth, matrix remodeling, and angiogenesis [141], further 
supporting tumor progression. Clinically, the presence of a CAF gene signature is 
associated with therapy resistance and poor prognosis [35]. Thus, MSCs and fibroblasts 
are potential therapeutic targets for metastatic cancer.  
 Though the recruitment of stromal cells in response to soluble factors has been 
well-documented [147,148], the involvement of cell adhesion is not fully understood. 
Cell adhesion molecules, including cadherins and integrins, play a critical role in cancer 
progression. Alterations in cell adhesion molecules are associated with EMT, a 
mechanism by which cancer cells become invasive [43]. EMT is characterized by 
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disruption of cell-cell junctions, including loss of endothelial cadherin 1 (E-cadherin), 
and gain of cadherin 2 (N-cadherin), cadherin 11 (OB-cadherin), as well as cell-ECM 
adhesions, including α5β1 integrin [43]. Gain of cadherin 2 expression is linked to 
increased invasiveness and survival of tumor cells [149] and increased expression of 
α5β1 integrin is linked with poor prognosis and metastasis [36]. In addition, cadherin 11 
has been implicated in breast [150] and prostate cancer [151] metastasis. Evidence of 
EMT has been observed at the invasive front of colorectal cancer [45], in metastatic 
ovarian cancer [46], and circulating breast cancer cells [152], suggesting this transition is 
critical for metastasis. 
 In this study, we sought to understand if these changes in cell adhesion molecules 
during cancer progression affected the engraftment of stromal cells such as fibroblasts 
and MSCs. We show that stromal cells are more adherent to invasive cancer cells than 
non-invasive cells. Integrins are not required for these cell-cell interactions, but cadherins 
are critical for stromal cell attachment to invasive cancer cells. Cadherin 11 and 2 were 
colocalized at sites of adhesion and blockade of cadherin 11 on stromal cells reversed this 
adhesive response, providing insight into stromal cell engraftment in invasive tumors. 
6.3 Results 
6.3.1 Stromal cells are more adherent to invasive cancer cells 
 In order to probe the adhesion of stromal cells (fibroblasts and MSCs) to non-
invasive and invasive cancer cells, a fluorescence-based plate reader assay was utilized. 
Both stromal cell types were more adherent to invasive than non-invasive breast and 







Figure 6.1 Stromal cells attach and spread more on invasive cancer cells. Fibroblasts and 
MSCs were more adherent on invasive breast (A), prostate (B), ovarian (C), and 
chemoresistant ovarian cancer cells (D). Fibroblasts were labeled with CFSE and allowed 
to spread on cancer cells for 24 hours followed by counterstaining with DAPI (right 







A similar trend was found comparing adhesion to ovarian cancer cell lines SKOV3 and 
OVCAR3 (Figure 6.1C) and their chemoresistant counterparts SKOV3T and OVCAR3T 
(Figure 6.1D). Stromal cells adhesion was significantly increased on chemoresistant 
compared to chemoresponsive ovarian cancer cells (OVCAR3 vs. OVCAR3T, SKOV3 
vs. SKOV3T, p<0.001). In addition, fibroblasts and MSCs were able to spread more on 




Figure 6.2 MSCs spread more on invasive cancer cells. MSCs were labeled with CFSE 
and seeded on cancer cell monolayers for 24 hours followed by labeling nuclei (blue). 




6.3.2 Stromal cell adhesion to cancer cells is not mediated through soluble factors or 
integrins 
 Previous studies have demonstrated that conditioned media (CCM) derived from 
non-invasive cancer cells differs from CM from invasive cancer cells [153,154]; 
consequently, we tested whether the increase in adhesion to invasive cancer cells was due 
to differences in soluble factor secretion. The accumulation of soluble factors (24 hr 






Figure 6.3 Stromal cell adhesion to cancer cells is mediated by cadherins. The 
accumulation of soluble factors (24 hr CCM) did not have a significant effect on MSC 
adhesion to MCF7 or MDA-MB-231 (A). Chelation of Ca2+ with EGTA decreased 
fibroblast adhesion to MDA-MB-231, SKOV3, and PC3 (B). β1 inhibition with 10 
μg/mL antibody did not significantly decrease the adhesion of stromal cells to breast (C) 











To determine if stromal cell adhesion to invasive cancer cells is mediated through 
integrins or cadherins, integrins were activated with Mg2+ and ethylene glycol tetraacetic 
acid (EGTA) [155]. Cadherins are Ca2+ dependent; thus, chelation of Ca2+ with EGTA 
will also deactivate cadherins. Stromal cell adhesion was not increased with the addition 
of EGTA (Figure 6.3B), suggesting that it is not integrin mediated. To confirm stromal 
cells were not adhering to invasive cancer cells through integrins, β1 integrin, which has 
been shown to be highly expressed in invasive breast [156] and ovarian cancer [157], was 
blocked. Blockade of β1 integrin did not reverse adhesion to breast or ovarian cancer 
cells (Figure 6.3C,D). These results suggested stromal cell adhesion is mediated by 
cadherins. 
6.3.3 Cadherin 11 and 2 are highly expressed in stromal cells and invasive cancer 
cells 
 Integrin activation and inhibition experiments suggested that stromal cell 
adhesion to invasive cancer cells is mediated through cadherins (Figure 6.3). Non-
invasive cancer cells can utilize EMT, a process by which cancer cells alter cell-cell and 
cell-ECM adhesion, to acquire a migratory or invasive phenotype [43]. This transition is 
characterized by increased expression of cadherin 2 (N-cadherin) and cadherin 11 (OB-
cadherin) [43]; thus, immunostaining was performed for these two proteins. Fibroblasts 
and MSCs expressed high levels of cadherin 11 and 2 (Figure 6.4A). Invasive breast and 
prostate cancer cells express high levels of cadherin 11 whereas non-invasive cells do not 
(Figure 6.4B,C). Although invasive prostate cancer cells (PC3) express cadherin 2 






Figure 6.4 Cadherin 11 and 2 are highly expressed in stromal cells and invasive cancer 
cells. Immunofluorescent images of fibroblasts and MSCs (A), and breast (B), prostate 
(C), ovarian (D), and chemoresistant ovarian cancer cells (E) labeled for cadherin 2 (red), 
cadherin 11 (green), and nuclei (blue). Scale bar=50 μm. Cadherin intensity was 
calculated as the integrated intensity of the segmented cadherin divided by the total 
number of cells (nuclei) per image. To account for batch differences in light intensity, 






Ovarian cancer cells did not express cadherin 11; however, invasive ovarian cancer cells 
express high levels of cadherin 2. Expression of cadherin 2 was further increased in 
chemoresistant compared to chemoresponsive ovarian cancer cells (Figure 6.4D,E). 
6.3.4 Stromal cell adhesion to invasive cancer cells is mediated through cadherin 11 
interactions 
 High expression of cadherin 11 in stromal cells coupled with increased expression 
of cadherin 11 in invasive cancer cells suggested stromal cells may utilize this protein to 
attach to invasive cancer cells. Blocking cadherin 11 on fibroblasts significantly reduced 
their adhesion to invasive breast and ovarian cancer cells (Figure 6.5A), although 
invasive ovarian cancer cells do not express cadherin 11 (Figure 6.4). A similar trend 
was observed with MSCs (Figure 6.5B). A higher concentration of antibody was 
required to block adhesion, in agreement with increased cadherin 11 expression (Figure 
6.4A). Immunostaining for cadherin 11 and 2 revealed cadherin 11 colocalizes with 
cadherin 2 at sites of cell-cell adhesion in both fibroblasts and MSCs (Figure 6.5C). 
Cadherin 11 and 2 were also colocalized at sites of adhesion of fibroblasts to MDA-MB-
231 and SKOV3, but not MCF7 or OVCAR3 (Figure 6.5D).  A similar trend was found 







Figure 6.5 Stromal cell adhesion to invasive cancer cells is mediated through cadherin 11 
interactions. Fibroblast (A) and MSC (B) adhesion to MDA-MB-231 and SKOV3 is 
decreased with cadherin 11 blocking antibody. Immunofluorescent images of cells 
labeled for cadherin 2 (red), cadherin 11 (green), and nuclei (blue) with zoomed images 
of highlighted regions revealed cadherin 2 and 11 colocalize at sites of cell-cell adhesion 
(C). Fibroblasts were labeled with CFSE (white). Cadherin 2 and 11 colocalize at sites of 
fibroblast adhesion to MDA-MB-231 and SKOV3 but not MCF7 and OVCAR3 (D). 








Figure 6.6 MSC adhesion to invasive cancer cells is mediated through cadherin 11 
interactions. Immunofluorescent images of cells labeled for cadherin 2 (red), cadherin 11 
(green), and nuclei (blue) with zoomed images of highlighted regions. MSCs were 
labeled with CFSE (white). Cadherin 2 and 11 colocalize at sites of MSC adhesion to 





 Soluble factors from fibroblasts are known to promote cell transformation and 
tumor growth [158]. Likewise, MSCs secrete soluble factors such as CCL5, IL6, TGFβ, 
VEGF and SDF-1 that promote tumor progression by increasing cancer cell proliferation, 
migration, and invasion [29]. Previous studies have demonstrated that MSCs must be in 
close proximity to cancer cells to induce CCL5 secretion required for increased cancer 
cell migration and invasion [28]. Both cell types induce angiogenesis within the tumor, 
allowing for influx of nutrients for growth as well as additional avenues for escape [141]. 
In addition, fibroblasts are primed by interstitial flow to remodel the ECM to promote 
invasion [159]. Fibroblast remodeling of the matrix generates tracks for cancer cells to 
follow promoting collective invasion [160]. High expression of EMT markers has been 
observed at this invasive front of tumors [141], which may subsequently recruit more 
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stromal cells, further promoting cell invasion. Consequently, increased engraftment of 
stromal cells on invasive cancer cells observed in this study may further promote the 
proliferative and invasive properties of cancer cells. 
 Non-invasive cells display an epithelial phenotype characterized by high levels of 
cadherin 1 and low levels of cadherin 2 [43]. Homotypic cadherin 1 bonds are 
significantly stronger than homotypic cadherin 2 and 11 bonds; however, heterotypic 
cadherin 1 and 2 bonds infrequently form [161,162]. Previous studies have demonstrated 
that MSCs form adherens junctions with MCF7 cells consisting of MCF7 cadherin 1 and 
MSC cadherin 2, and blocking either of these proteins, but not cadherin 11, abolishes cell 
adhesion [163]. Cadherin 2 was present at sites of stromal cell adhesion to non-invasive 
cells (Figure 6.5, 6.6), suggesting that this is the mechanism of adhesion to non-invasive 
cells. Few stromal cells were able to attach and spread on non-invasive cells; thus, this 
type of adhesion may not be conducive for long-term stromal cell engraftment. 
Homotypic cadherin 11 bonds are stronger than cadherin 2 junctions [164]; consequently, 
enhanced adhesion to invasive cancer cells may be a result of differences in bond 
strength. Stromal cell adhesion was enhanced on PC3 compared to MDA-MB-231 and 
SKOV3 (Figure 6.1), and this is associated with enhanced cadherin 11 expression of PC3 
(Figure 6.4), further supporting this mechanism.  
 Stromal cells were largely unable to spread on non-invasive cancer cells, but were 
able to do so on invasive cancer cells. The inability of cells to spread has been associated 
with apoptosis [165]; thus, the inability of stromal cells to spread on non-invasive cancer 
cells may reduce their long term survival. Cell spreading [19] and cadherin 11 expression 
[8,166] are also critical in MSC differentiation and fibroblast differentiation into tumor-
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promoting myofibroblasts [8,166], which are thought to have similar characteristics to 
cancer-associated fibroblasts (CAFs) [34]. In addition, cadherin 11 is upregulated in 
myofibroblasts and is important for contractile activity [33]. Enhanced contractility of 
stromal cells leads to matrix remodeling that promotes cancer cell growth, survival, and 
invasion [33]. This suggests that stromal cells recruited to invasive tumors may be more 
likely to differentiate into myofibroblasts or CAFs and further promote invasion and 
metastasis.   
 Surprisingly, blocking cadherin 11 on stromal cells reversed their adhesion to 
invasive SKOV3 cancer cells that do not express cadherin 11. Cadherins typically form 
homotypic junctions; however, cadherin 11 has been shown to bind to cadherin 2 [167]. 
Immunofluorescent images of adhesion sites of stromal cells to SKOV3 displayed 
colocalization of cadherin 11 with cadherin 2 (Figure 6.5D), suggesting stromal cells 
utilize cadherin 11 to bind to both cadherin 2 and 11, which are frequently expressed on 
invasive cancer cells that have undergone EMT [150,151]. In addition, EMT has been 
linked to chemoresistance [168]. Consequently, this mechanism of adhesion may be 
conserved across many types of cancer and is a potential therapeutic target for metastatic 
cancer. Blocking cadherin 11 with the FDA-approved rheumatoid arthritis drug celecoxib 
has inhibited the growth of glioblastoma, breast, and prostate cancer cells [169]. This 
suggests that in vivo cadherin 11 inhibition may have effects on both tumor cell growth 
and stromal cell recruitment. 
6.5 Conclusions 
 Our studies showed that stromal cells preferentially adhere to invasive breast, 
ovarian, and prostate cancer and chemoresistant ovarian cancer cells. Sites of stromal cell 
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adhesion to invasive cancer cells were characterized by colocalization of cadherin 11 and 
2. Blocking cadherin 11 on stromal cells reversed adhesion to invasive cancer cells. 
These studies elucidate how stromal cells attach to cancer cells by cadherin-mediated 
interactions and provide a new approach for treating invasive cancers by targeting cell 
adhesion molecules on stromal cells.  
6.6 Materials and Methods 
6.6.1 Cell Culture 
 Human MSCs (Donor 7071L) were obtained from Texas A&M Institute for 
Regenerative Medicine and cultured in αMEM (Corning) with 20% FBS (Atlanta 
Biologicals), 1% penicillin-streptomycin (Corning), and 1% L-glutamine (Corning). Cell 
lines Hs27 (foreskin fibroblasts), MCF7 (non-invasive breast cancer), OVCAR3 (non-
invasive ovarian cancer), SKOV3 (invasive ovarian cancer), DU145 (non-invasive 
prostate cancer), and PC3 (invasive prostate cancer) were obtained from ATCC and 
cultured in RPMI (Corning) with 10% FBS and 1% penicillin-streptomycin. MDA-MB-
231 (invasive breast cancer) were obtained from ATCC and cultured in low glucose 
DMEM (Corning) 10% FBS and 1% penicillin-streptomycin. Chemoresistant OVCAR3 
(OVCAR3T) and SKOV3 (SKOV3T), which are characterized by a 10-fold higher IC50 
value than chemoresponsive OVCAR3 and SKOV3, were isolated by repeated exposure 
to 10 nM Taxol and allowed to recover as described [157]. 
6.6.2 Adhesion Assays 
 MSCs or fibroblasts were labeled with calcein AM (Enzo) and allowed to adhere 
on cancer cell monolayers in HBSS (Corning) with 100 mM CaCl2 and 100 mM MgSO4 
for 1 hour before taking an initial fluorescence reading. Plates were rinsed with HBSS to 
82 
 
remove non-adherent cells and a final reading was taken. Adherent fraction was 
calculated as the final reading divided by initial reading after subtraction of background 
fluorescence. To determine the effect of soluble factors on adhesion, serum-free DMEM 
was added to cancer cell monolayers for 24 hours (24 hr CCM condition). For 0 hr CCM, 
serum-free DMEM was replaced immediately before seeding MSCs to remove 
accumulated soluble factors. MSCs were labeled with carboxyfluorescein succinimidyl 
ester (CFSE, Biolegend) and allowed to adhere on cancer cell monolayers in serum-free 
DMEM for 1 hour before taking an initial fluorescence reading, then rinsing with serum 
free DMEM, and taking a final fluorescence reading. In order to activate integrins, 
fibroblasts were labeled with CFSE and incubated with 100 mM MgSO4 and 1 mM 
EGTA (Corning) [155]. For integrin blocking experiments, fibroblasts were incubated 
with 10 μg/mL β1 integrin antibody (DSHB) for 30 minutes prior to seeding on cancer 
cell monolayers. In order to block cadherin 11, 10 μg/mL cadherin 11 antibody (R&D 
Systems) was used for fibroblasts and 15 μg/mL cadherin 11 antibody for MSCs. 
Titration experiments were performed for MSCs, as they displayed increased expression 






Figure 6.7 Cadherin 11 antibody titration for MSCs. MSCs were treated with increasing 
concentrations of cadherin 11 antibody until adhesion was inhibited at 15 μg/mL. 
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6.6.3 Immunofluorescence Assays 
 For imaging of cadherin 2 and 11, cells seeded on glass coverslips were fixed 
with 4% formaldehyde, blocked with 5% horse serum (Sigma Aldrich), followed by 
incubation with human cadherin 11 antibody, Dylight 650 conjugated rabbit anti-goat 
antibody (Thermo Scientific), human cadherin 2 antibody (Biolegend), and Alexa Fluor 
547 conjugated goat anti-mouse antibody (Invitrogen) for 1 hour each. Cells were 
counterstained with DAPI (Anaspec) and coverslips sealed with Vectashield (Vector 
Labs). Cells were imaged using a Nikon Eclipse Ti microscope at 40x magnification. For 
imaging of fibroblast adhesion to cancer cells, fibroblasts were labeled with CFSE and 
allowed to adhere for 24 hours prior to staining as described above. Cells were imaged 
using a Nikon Eclipse Ti microscope at 100x magnification. 
6.6.4 Image Quantification 
 Nuclei were segmented using a 3 standard deviation threshold above the mean 
following band pass filtering. Nuclei centers were determined as local maximums of band 
passed images and used to separate any touching nuclei by a seeded watershed method 
[170]. Cadherin images were segmented using Otsu’s method following median filtration 
and background subtraction. Cadherin density was defined as the integrated intensity of 
the segmented region divided by the total number of cells per image as determined from 
the nuclei segmentation. To account for batch differences in light intensity, each 
experiment was normalized to its respective average. 
6.6.5 Statistical Analysis 
 All experiments were performed in triplicate or more. A student’s t-test was used 
for all statistical analysis with p<0.05 being statistically significant (* p<0.05, ** p<0.01, 
84 
 
*** p<0.001). ANOVA with a Tukey post-hoc test was utilized for comparison of 
OVCAR3 and SKOV3 to OVCAR3T and SKOV3T. Data were reported as the mean ± 




MESENCHYMAL STEM CELLS INDUCE THE DIRECTIONAL MIGRATION 




 MSCs are recruited to the tumor microenvironment and influence tumor 
progression; however, how MSCs induce the invasion of cancer cells is not completely 
understood. Here, we used a 3D coculture model to determine how MSCs affect the 
migration of invasive breast cancer cells. Coculture with MSCs increases the elongation, 
directional migration, and traction generation of breast cancer cells. While PDGFR is 
important for breast cancer cell directional migration when cultured alone, this pathway 
is dispensable in coculture. MSC-induced directional migration directly correlates with 
force generation and is mediated by TGFβR and the migratory proteins ROCK, FAK, and 
MMPs. Treatment with recombinant TGF-1 elicits a similar migration response to 
coculture. Taken together, this work suggests TGF- is secreted when breast cancer cells 
are cocultured with MSCs, leading to force-dependent directional migration of invasive 
cancer cells. These pathways may be potential targets for blocking cancer cell invasion 
and subsequent metastasis. 
7.2 Introduction 
 The tumor microenvironment consists of malignant cells, a network of ECM 
proteins, and a variety of recruited cells. All of these components dynamically interact to 
influence cancer progression. These interactions are mediated by chemical signals, 
including cytokines, chemokines, growth factors, and matrix remodeling proteins. In 
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addition, mechanical signals provided by the tumor microenvironment can have profound 
effects on tumor progression [33]. Drugs that minimize the crosstalk between cells in the 
tumor microenvironment have been proposed as potential targets for cancer prevention 
[171] and treatment [26,172]. A number of drugs targeting different components of the 
microenvironment, including blood vessels, ECM, fibroblasts, and immune cells, have 
been developed [26]. Sibrotuzumab was developed to target fibroblast activation protein 
(FAP), which is involved in matrix degradation and is expressed by fibroblasts in the 
tumor microenvironment[31]. In addition, imatinib targets receptor tyrosine kinases 
(RTKs) critical for fibroblast function [26]. 
 MSCs are recruited from the bone marrow and local adipose tissue [144] in 
response to tumor-secreted soluble factors [48,78]. Gene expression of stromal cells is 
indicative of patient prognosis [35], suggesting these recruited cells play a critical role in 
regulating tumor progression. MSCs promote the growth of tumors through 
differentiation into CAFs, angiogenesis induction, and secretion of growth factors [27]. 
While local adipose-derived MSCs express markers characteristic of vascular stroma 
(NG2, CD31, αSMA), stromal cells derived from bone marrow MSCs express high levels 
of CAF-associated markers FAP and fibroblast specific protein (FSP), both of which are 
thought to be critical for invasion and metastasis [144]. MSCs can also induce the 
metastasis of breast tumors through secretion of soluble factors such as of CCL5 [28] and 
enhancing cancer stem cell properties [173]. Thus, a better understanding of how MSCs 
induce the invasive properties of cancer cells could provide potential therapeutic targets 
for metastatic cancer. 
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The ECM also plays a critical role in cancer progression. During breast cancer 
progression, stromal cells deposit fibrillar collagen [174], which increases cancer cell 
proliferation and invasion [175]. In addition, the mechanical properties of the ECM can 
induce a malignant phenotype [40], promote tumor progression [176], and are critical for 
the generation and maintenance of the CAF phenotype [177]. In order to migrate in 3D 
environments, cancer cells must navigate and remodel dense ECM [178–181]. Two major 
types of migration are utilized by individual cancer cells to migrate in 3D: amoeboid and 
mesenchymal. Amoeboid migration is characterized by rounded cells that circumnavigate 
ECM without the use of adhesion proteins or matrix degradation; whereas for 
mesenchymal migration, cells elongate, establish integrin-mediated adhesion to the ECM, 
degrade ECM with matrix metalloproteinases (MMPs), and contract the cell body via 
MLCK, Rho, and ROCK [182]. Previous studies have demonstrated that fibroblasts 
utilize Rho-mediated matrix remodeling to generate tracks to enable the invasion of 
cancer cells [160]. In addition, interstitial flow causes fibroblasts to reorganize collagen 
fibers through Rho, which promotes cancer cell invasion [159]. Fibroblasts have similar 
gene expression profiles [183] and immunomodulatory properties [184] to MSCs; thus, 
we hypothesized that MSCs may induce the invasion of cancer cells through similar 
mechanisms. 
 In this study, we show that coculture with MSCs causes MDA-MB-231 invasive 
breast cancer cells to elongate and directionally migrate. Small molecule inhibitor studies 
revealed MSC-induced directional migration is mediated by TGF-, ROCK, FAK, and 
MMPs, but not PDGF or VEGF. Force generation appeared to be critical for cancer cell 
migration, as directional migration directly correlated with traction generation. Treatment 
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of cancer cells with recombinant TGF-1 elicited a strikingly similar response to MSC 
coculture, suggesting that TGF- secreted in coculture activates ROCK, FAK, and MMPs 
to facilitate the directional migration of cancer cells. These results elucidate how MSCs 
induce breast cancer cell invasion and may provide therapeutic targets to prevent invasion 
and metastasis. 
7.3 Results 
7.3.1 Coculture with MSCs induces the elongation and directional migration of 
breast cancer cells 
 Alterations in cell shape are critical for cell migration in 3D [42]; thus, we 
characterized morphological changes after coculture. MDA-MB-231 breast cancer cells 
(MDA) cultured alone in collagen gels remained largely unspread (Figure 7.1A). Upon 
coculture with MSCs, MDA appeared more elongated (Figure 7.1B). Quantification of 
the aspect ratio of cells revealed MDA were significantly more elongated in coculture 





Figure 7.1 Breast cancer cells display an elongated phenotype in coculture. Images of 
invasive breast cancer cells (MDA-MB-231, MDA) cultured alone (A) and in coculture 
with MSCs (green, B). (C) MDA were significantly (P<0.01) more elongated in 
coculture. * P<0.05, ** P<0.01, *** P<0.001. 
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 Cell elongation has been associated with enhanced tumor cell invasion and 
metastasis [182]; consequently, we next evaluated cell migration of MSCs and MDA-
MB-231 in collagen gels (Figure 7.2A). MSCs moved in a directional manner, but the 
presence of MDA did not increase their directional migration (Figure 7.2B). The 
migration of MDA was more random, which corresponded to a lower directional velocity 
than MSCs (Figure 7.2B,C). Coculture with MSCs led to an increase in MDA directional 
velocity which is critical for cancer invasion [185] (Figure 7.2C) as well as random 




Figure 7.2 Coculture induces the migration of breast cancer cells but not MSCs. (A) 
Traces of MSC and MDA migration alone and in coculture. The directional migration of 








Figure 7.3 TGFβR is involved in directional migration but not overall motility. MDA 
were treated with control media (CTRL, SF DMEM), ROCK inhibitor (1 μM H-1152), 
FAK inhibitor (20 μM PF-573228), MMP inhibitor (20 μM GM-6001), RTK inhibitor (1 
μM Sunitinib) or TGFβR inhibitor (1 μM SB-505124). Mean velocity does not 
significantly correlate with max bead displacement (ρ=0.33, P=0.09). Significance is 
indicated relative to MDA control cells with *’s and relative to MDA+MSC with #’s. * 




 In order to determine if MSC-induced directional migration is specific to invasive 
breast cancer cells, we cocultured MSCs with the non-invasive breast cancer cell line 
MCF7. MSCs did not induce a significant increase in random or directional migration of 
MCF7 (Figure 7.4), indicating the MSC-induced migration observed is specific to 






Figure 7.4 MSCs do not induce the migration of non-invasive breast cancer cells. The 
random (mean velocity) and directional migration (directional velocity) of MCF7 alone 
and in coculture with MSCs. Mean velocity and directional velocity were not 




7.3.2 MSC-induced directional migration is mediated through TGFβR and 
mechanotransduction pathways 
 Cell elongation has been associated with the mesenchymal mode of migration, 
where cells utilize cell contractility, focal contacts, and MMPs to migrate [182]; thus, we 
hypothesized these pathways may be involved in MSC-induced directional migration of 
MDA. We targeted cell contractility with a ROCK inhibitor (H-1152), adhesion turnover 
with a FAK inhibitor (PF-573228), and MMP activity with a MMP inhibitor (GM-6001). 
Inhibition of these proteins decreased the directional velocity of MDA cultured alone 
(Figure 7.5A). In addition, differences in directional migration between MDA alone and 
MDA in coculture with MSCs were abrogated with inhibition of ROCK, FAK, and 
MMPs (Figure 7.5A), suggesting these pathways are critical for MSC-induced migration. 
In order to determine the signal upstream of these pathways, we targeted growth factor 
receptors known to be associated with breast cancer prognosis and metastasis, VEGFR, 







Figure 7.5 MSCs induce the directional migration of invasive breast cancer cells through 
TGFβR and downstream mechanotransduction pathways. (A,B) The directional velocity 
of MDA treated with inhibitors. (C) Directional velocity coefficient of variation was 
calculated. (D) Percentile curves of the directional velocities of MDA in coculture with 
MSCs. (E) Directional velocity was normalized to the mean directional velocity control 
cells to determine relative changes in the most motile cells versus average cells. 
Significance is indicated relative to MDA control cells with *’s and relative to 





Inhibition of VEGFR and PDGFR with a RTK inhibitor (Sunitinib) decreased the 
directional velocity of MDA alone; however, it failed to reduce the MSC-induced 
directional migration response. In contrast, TGFR did not alter MDA directional 
migration when cultured alone, but inhibition of this pathway abolished the MSC-induced 
directional migration response (Figure 7.5B). These results suggest that while VEGFR 
and PDGFR are important for cancer cell migration, they do not mediate this MSC-
induced directional migration, which is controlled by TGFR. 
7.3.3 Inhibitors primarily target most motile cells 
  Heterogeneity in tumor cells has been well documented in breast cancer [189]; 
thus, we looked at heterogeneity in the directional velocity of breast cancer cells. Both 
MDA alone and in coculture with MSCs had a high coefficient of variation, indicating 
that their migration varied widely, similar to the heterogeneous gene expression observed 
in breast tumors [189]. We also used the coefficient of variation in directional velocity to 
determine if MDA were responding heterogeneously to inhibition of pathways critical for 
MSC-induced migration. Treatment with inhibitors generated a more homogenous 
distribution of velocities (Figure 7.5C). ROCK, FAK, and MMP inhibition were 
associated with the lowest coefficients of variation. In coculture, MDA treated with both 
MMP and RTK inhibitors had a higher degree of heterogeneity in directional velocity 
compared to MDA cultured alone. The opposite trend was observed with TGFR 
inhibitor treated cells, suggesting this inhibitor elicits a more homogenous response in 
coculture where TGFR is more critical for migration. To further determine what was 
leading to this observed heterogeneous response, we sorted the directional velocities my 
magnitude and plotted their values as percentile curves of directional velocities for MDA 
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in coculture with MSCs. The percentile curve was steep for MDA control cells indicating 
a more heterogeneous distribution of velocities, but after molecular inhibition, the curves 
were more shallow indicating reduced variation in directional velocity (Figure 7.5D). 
Next, we compared the directional velocity of the 90th and 50th percentiles normalized to 
the control values for these percentiles; this is a measure of the inhibitor response in the 
fastest and the average moving cells (Figure 7.5E).  ROCK, RTK and TGFR inhibition 
elicited similar responses, with the top 10% most motile cells displaying the larger 
differences from non-treated cells compared to average moving cells (Figure 7.5E). This 
suggests that these inhibitors primarily target the most motile cells, with much smaller 
effects on less motile cells, whereas other inhibitors target all cells to a similar extent. 
FAK and MMP inhibitors had large effects on both the most motile cells and average 
moving cells; however, the decrease in directional velocity compared to control cells was 
similar for each of these percentiles. This indicates that in contrast to ROCK, RTK and 
TGFR inhibition, FAK and MMP inhibition more equally targets all cells. 
7.3.4 MSCs induce cancer cell force generation which is critical for directional 
migration 
 Force generation has been implicated in tumor progression [40] and cell motility 
[190] and is critical for the mesenchymal mode of migration [182]; thus, we measured the 
displacement of beads embedded in the collagen gel while cells were migrating. 
Coculture with MSCs increased the displacement of beads, and inhibition of ROCK, 
FAK, or MMPs abrogated this increase (Figure 7.6A). ROCK inhibition, but not FAK or 
MMP inhibition, was associated with decreased traction generation compared to non-
treated MDA cultured alone. In addition, RTK inhibition did not significantly alter 
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traction generation (Figure 7.6B) or MSC-induced migration (Figure 7.5B). Inhibition of 
TGFR did not significantly alter traction for MDA cultured alone; however, it did lead 





Figure 7.6 MSCs induce cancer cell force generation which is critical for directional 
migration.   (A, B) Max bead displacement exerted by MDA. (C) Directional velocity 
correlates with max bead displacement (ρ=0.455, P<0.001). (D) Cells treated with FAK 
inhibitor (identified with blue circle) were identified as outliers (P<0.05) and excluded 
from analysis, which generated a stronger correlation between directional velocity and 
max bead displacement (ρ=0.610, P<0.001). Significance is indicated relative to MDA 




These results appeared to follow trends seen with directional velocity (Fig 7.5), 
suggesting that traction generation may be required for directional migration. We 
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performed correlational analysis and found directional velocity correlated with bead 
displacement across all experimental conditions (slope=0.441, ρ=0.455, P<0.001, Figure 
7.6C). We identified outliers in the correlation using studentized deleted residuals and 
observed that all outliers were cells treated with FAK inhibitor. This suggests that while 
active FAK is required for adhesion turnover necessary for directional migration, it is not 
integral for traction generation. After removal of FAK-treated cells from analysis, a 
stronger correlation between directional velocity and max bead displacement was 
observed (=0.610, P<0.001, Figure 7.6D). 
 
7.3.5 TGFβ treatment induces directional migration similar to MSC coculture 
 In order to verify that TGF-1 was the primary factor leading to increased 
directional migration in coculture, we treated with growth factors known to be secreted 
by MSCs [29] that signal through TGFR and RTKs to test if they induce a similar 
response. Treatment with TGF-1 elicited a similar migration response to MSC coculture 
(Figure 7.7A). To further verify these findings, we also treated with recombinant PDGF-
BB and VEGF-165, the ligands for the primary receptors targeted by the RTK inhibitor 
Sunitinib. PDGF-BB treatment induced directional migration; however, it did not 
increase migration to the degree TGF-1 or coculture did. VEGF did not induce 
migration of MDA. These data suggest that the TGF- pathway is primarily responsible 
for the migration observed in coculture. We then inhibited mechanotransduction 
pathways to determine if TGF- was signaling through ROCK, FAK, and MMPs. 
Treatment with TGF- in combination with these inhibitors elicited responses similar to 
coculture (Figure 7.7B). Together these data suggest that coculture leads to secretion of 
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TGF- which acts through ROCK, FAK, and MMPs to induce the directional migration 





Figure 7.7 TGFβ treatment induces directional migration similar to coculture. (A) 
Directional velocity of MDA cocultured with MSCs or treated with 10 ng/mL TGF-β1, 
10 ng/mL PDGF-BB, or 100 ng/mL VEGF-165. (B) Directional velocity of MDA 
cocultured with MSCs or treated with 10 ng/mL TGF-β1 with inhibitors. (C) Schematic 
of proposed mechanism of MSC-induced directional migration of breast cancer cells, 
where TGF-β is secreted in coculture which leads to activation of ROCK, FAK, and 





 TGF- signaling is critical for directional migration (Figure 7.5B); however, 
inhibition of TGFR had negligible effects on random motility (Figure 7.3). Directional 
invasion through ECM is thought to be a critical step for breast cancer metastasis [185], 
suggesting MSCs may contribute to metastasis by increasing directional migration. 
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Blockade of ROCK and FAK abolished increased random motility in coculture, 
suggesting these pathways are critical for both directional and random migration. Both 
PDGFR and MMP inhibition decreased random motility, but there was still a significant 
increase in velocity in coculture. Mean velocity had a weaker correlation with traction 
generation (=0.330, P=0.09) than directional velocity (Figure 7.3), indicating TGFR is 
primarily involved in traction-dependent directional but not random motility.  
 Active FAK is required for MSC-induced directional migration (Figure 7.5A) 
and increased traction generation (Figure 7.6A). Previous studies have demonstrated that 
depletion of FAK hinders migration and force generation in 3D environments [190]; 
however, in 2D FAK depletion and FAK inhibition elicit different force responses [191]. 
Phosphorylation of the Y397 site of FAK, which is targeted by PF-573228, is critical for 
force generation [192]. This site is phosphorylated by TGF-[193] and has been shown 
to be critical for growth factor-stimulated migration [194]. Treatment with TGF- in 
conjunction with FAK inhibition elicited a similar migration response to coculture 
(Figure 7.7B), suggesting that TGF- is secreted in coculture which leads to FAK-
mediated migration. FAK inhibitors have been proposed as a way to target cancer stem 
cells and alter chemoresistance, angiogenesis, inflammation, and profibrotic signals 
[195]. Our findings suggest that FAK inhibitors may also target MSC-induced directional 
migration. 
 FAK inhibitor-treated cells were outliers in the correlation between directional 
velocity and traction generation (Figure 7.6C). Bead displacements exerted by cells 
treated with FAK inhibitor were high (Figure 7.6A) compared to the low directional 
velocities of these cells (Figure 7.5A) indicating the decreased velocity observed after 
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FAK inhibition is not entirely due to decreased traction generation. Focal adhesion 
formation and turnover is mediated by FAK [195], which are critical for migration in 3D 
[182]. Although MDA can still generate force after treatment with a FAK inhibitor 
(Figure 7.6A), focal adhesion dynamics are blocked leading to inhibited migration 
(Figure 7.5A). FAK activation also increases the expression of MMP9 [196], which in 
addition to cleaving ECM to facilitate migration can proteolytically activate TGF-
[197]. Traction generated by MDA treated with FAK and MMP inhibitors were similar 
(Figure 7.6A), suggesting that these two molecules may act in conjunction to promote 
the activation of TGF-. In addition, similar migratory responses were observed with 
coculture and TGF- treatment, indicating that secreted TGF- may activate FAK and 
MMPs to facilitate migration. Blockade of TGFR in coculture inhibited migration 
(Figure 7.5B), further supporting the hypothesis that active TGF- signaling is required 
for increased directional migration of cancer cells. 
 Mesenchymal cells primarily utilize adhesions and cell contractility, which is 
mediated by Rho and ROCK, to migrate [182]. Rho also regulates actin organization, 
which is critical for 3D migration [182]. ROCK inhibition acts to decrease both 
directional migration and traction generation in MDA (Figure 7.5A, 7.6A). Previous 
work has shown MDA require Rho-mediated contractility to invade into Matrigel [198]. 
Rho has also been implicated in the alignment of ECM fibers to facilitate invasion [199]. 
Our findings suggest that ROCK is also critical for MSC-induced traction generation 
required for the directional migration of cancer cells. Increased matrix stiffness can 
generate a malignant phenotype, increase force generation, and activate Rho [40]. 
Coculture with MSCs was associated with higher traction (Figure 7.6A), suggesting that 
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MSCs may also play a role in altering the tensional homeostasis of cancer cells, similar to 
ECM stiffness [40]. Previous studies have demonstrated that in 2D MSCs alter their 
contractile gene expression in response to tumor-secreted factors [48,139] and display a 
myofibroblast phenotype after sustained exposure [30]. Myofibroblast contractility 
activates TGF in the ECM [200]; thus, MSC contractility may also contribute to TGF- 
activation in coculture with MDA. 
 Previous studies have demonstrated that PDGF activates Rac1 [201], which is 
required induce migration [202]. Our finding that PDGFR inhibition with Sunitinib does 
not alter traction generation (Figure 7.6B) is in agreement with previous studies that 
showed Rac1 inhibition has negligible effects on traction generation in 3D [190]. PDGFR 
inhibition did not significantly alter directional migration and traction generation in 
coculture, suggesting that this pathway is not required for MSC-induced migration. 
Inhibition of PDGFR in MDA cells cultured alone was associated with decreased 
directional migration and PDGF treatment did induce modest directional migration 
(Figure 7.7A), indicating this signal pathway does play a minor role in directional 
migration, but not to the same degree as TGF- (Figure 7.7A).  
 Inhibition of RTKs, TGFR, and downstream migration pathways led to 
differential responses (Figure 7.5). ROCK and FAK inhibition were associated with 
more homogenous distributions of directional velocity (low coefficient of variation) of 
MDA alone and in coculture, whereas MMP, RTK, and TGFR inhibition led to more 
heterogeneous responses (high coefficient of variation, Figure 7.5C). Cells may 
differentially activate these proteins, leading to a heterogeneous response to inhibitors. 
FAK, MMP, and RTK inhibition equally targeted the top 10% and 50% most motile 
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cells, suggesting these pathways are critical for directional migration of all cells (Figure 
7.5E). Both ROCK and TGFR appeared to be critical for the directional migration of the 
most motile cells, as inhibition of these pathways preferentially targeted the fastest 10% 
of cells. 
 These studies identify TGFR as a potential target to prevent MSC-induced breast 
cancer cell directional migration. MSCs differentiate into CAFs in response to soluble 
factors secreted by tumor cells [30]. Recent studies have shown the CAF phenotype is 
associated with poor patient prognosis and TGF- secreted by these cells can increase the 
frequency of tumor-initiating cells. By blocking TGF- crosstalk between CAFs and 
cancer cells, metastasis was blocked [35]. Our studies suggest the blockade of metastasis 
may have been in part to decreased directional migration of cancer cells, which is thought 
to be critical for escape from the primary tumor site [185]. TGF- can also directly 
induce EMT, where cells transition from an epithelial phenotype to an invasive 
mesenchymal phenotype allowing for escape from the primary tumor site [43]. EMT 
induced by TGF- has also been implicated in the activation of stromal cells to CAFs, 
which further promote tumor progression [31]. This indicates that TGF- secreted in 
coculture may induce EMT in addition to acting to directly increase directional migration 
through mechanosensitive pathways, further promoting metastasis. 
7.5 Conclusions 
 In conclusion, we demonstrated that MSCs induce the elongation and traction-
dependent directional migration of invasive breast cancer cells. Targeting TGF- 
signaling, ROCK, FAK and MMPs abrogates directional migration and force generation 
differences in coculture. These data suggest TGF- is secreted in coculture, which leads 
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to the activation of ROCK, FAK, and MMPs to mediate directional migration of breast 
cancer cells. Together, this work provides insight into MSC interactions with invasive 
breast cancer cells within the tumor microenvironment and potential therapeutic targets to 
halt invasion and metastasis. 
7.6 Materials and Methods 
7.6.1 Cell Culture 
 Human MSCs (Donor 7071) were obtained from Texas A&M Institute for 
Regenerative Medicine and cultured in αMEM (Corning) with 20% FBS (Atlanta 
Biologicals), 1% penicillin-streptomycin (Corning), and 1% L-glutamine (Corning). 
MDA-MB-231 cells (ATCC) were cultured in low glucose DMEM (Corning) 
supplemented with 10% FBS and 1% penicillin-streptomycin. MCF7 cells (ATCC) were 
cultured in RPMI (Corning) supplemented with 10% FBS and 1% penicillin-
streptomycin. 
7.6.2 Fabrication of 3D Collagen Gels 
 Cells were embedded in collagen gels as described [190]. MSCs were labeled 
with CFSE (Biolegend) in HBSS. Cells were mixed with 10X reconstitution buffer (200 
μM sodium bicarbonate and 200 μM HEPES in water) and 3 μm polystyrene particles 
(Polysciences) and added to rat tail collagen I to obtain a 2 mg/mL collagen gel. For 
coculture experiments, MSCs and MDA-MB-231 cells were mixed at a 1:1 ratio. Gels 
were polymerized on ice for 45 minutes followed by incubation at 37˚C for 2 hours 





7.6.3 Cell Migration Experiments 
 Cells were serum starved for at least 6 hours before imaging. ROCK (1 μM H-
1152, Enzo), FAK (20 μM PF-573228, Sigma), MMP (20 μM GM-6001, EMD 
Millipore), RTK (1 μM Sunitinib, Sigma), and TGFβR (1 μM SB-505124, Sigma) 
inhibitors were added 2 hours before imaging. For growth factor experiments, 10 ng/mL 
TGF-β1 (Biolegend), 10 ng/mL PDGF-BB (Biolegend), and 100 ng/mL VEGF-165 
(Biolegend) and inhibitors were added to cells 2 hours prior to imaging. Imaging was 
performed on a Nikon Eclipse Ti inverted epifluorescent microscope with a 10x 
objective. Cells were maintained at 37˚C with 5% CO2 using an In Vivo Scientific 
environmental cell chamber and a Bioscience Tools CO2 controller and imaged every 5 
minutes for 16 hours using a Photometrics CoolSNAP camera. For cell shape analysis, 
cells were manually traced in ImageJ software (NIH). The x-y coordinates of cells were 
determined using Metamorph software and used to evaluate motility parameters in a 
custom-written MATLAB algorithm. Cells that divided during the experiment were 
excluded from analysis. Cell velocities were calculated over 30 minute intervals and 
averaged to determine mean velocity. Directional velocity was calculated as the total 
distance traveled divided by time. Directional velocity coefficient of variation (standard 
deviation divided by the mean) and percentile analyses were calculated based on at least 
150 individual cells.  
7.6.4 Bead Displacement Quantification 
 Bead positions were identified as described with minor modifications and 
trajectories linked using a Hungarian linker algorithm [114,138]. In brief, bright field 
particle images were inverted to create a bright particle on a dark background. Next, a 
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bandpass filter was applied to the images before determining the particle centroid to 
subpixel resolution based on the intensity-weighted centroid. Only beads within a 75 μm 
radius of a cell were used for analysis; beads outside this radius were used to assess any 
drift over the course of imaging. Beads were assigned to each cell using a nearest-
neighbor algorithm which was verified manually for each video. The maximum 
displacement was determined for each bead, and then max bead displacement was taken 
as the top 95th percentile of displacements around each cell.    
7.6.5 Statistics 
 Data are reported as the mean ± SEM unless otherwise noted. A student t-test was 
used to determine significance with P<0.05 being statistically significant (* P<0.05, ** 
P<0.01, *** P<0.001). For correlation analysis, Pearson’s correlation coefficients were 
calculated in MATLAB, with ρ=-1 being perfectly negatively correlated and ρ=+1 being 
perfectly positively correlated. Studentized deleted residuals were used to identify 




CONCLUSIONS AND FUTURE DIRECTIONS 
 
 
 In this work, we determined the effect of biochemical and mechanical signals 
from the microenvironment on the regenerative and cancer-promoting properties of 
MSCs. We found intracellular mechanics and extracellular force generation are altered 
during MSC differentiation. In order to implement tissue engineered constructs clinically, 
it is important to have an understanding of MSC lineage commitment.  Current methods 
for detection of differentiation are staining [1] and PCR [48,114], which involve fixing or 
lysing the cells resulting in cell death. In addition, these techniques typically can only be 
used for cells that are relatively far into the differentiation process (~3-5 weeks). Our 
studies indicate that increases in the elastic character of the cytoplasm at 1 week into 
differentiation induction may be a marker of adipogenesis. MPTM can be performed on 
live cells and in cells embedded in 3D constructs [75], indicating that this technique may 
be useful for identifying differentiated cells for tissue engineering purposes. Future 
studies could be performed to monitor the rheological properties of MSCs during 
differentiation to evaluate if differentiation capacity can be detected earlier. This could be 
used to monitor tissue engineered constructs. In addition, we found that MSCs exerted 
higher traction stresses when cultured with adipogenic factors in stiff environments that 
were not conducive for adipogenesis. This suggests that manipulating force generation 
may be a way to promote more efficient directed differentiation. Together, these results 
have important implications for the design and testing of tissue engineered constructs. 
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 We also found biomaterial composition can dictate what factors direct 
differentiation. Typical biomaterial characterization techniques include scanning electron 
microscopy and bulk mechanical testing. While bulk mechanical testing was indicative of 
differentiation potential for 10% gelatin scaffolds, it did not predict differentiation 
potential for 5% gelatin scaffolds. Differentiation potential for 5% gelatin scaffolds was 
more dependent on the hydrated pore structure probed by MPTM. These results 
underscore the need for a variety of biomaterial characterization techniques. In addition, 
these results suggest that tailoring material architectural and mechanical properties may 
be a way to enhance directed differentiation. Previous studies have shown there is an 
optimum pore size for bone regeneration [137] and immune activation [203]; thus, there 
may also be an optimum pore size for MSC differentiation. MPTM could be performed 
simultaneously on the scaffold and the cells embedded in the scaffold to simultaneously 
monitor hydrated pore structure and differentiation of MSCs. The material architecture 
and mechanical properties could be tailored to manipulate force generation, further 
directing MSC lineage. Consequently, these studies may aid in the design of biomaterials 
for MSC-mediated tissue regeneration. 
 We next sought to understand the role of MSCs in tumor progression. We found 
cadherin 11 facilitates the adhesion of MSCs to invasive cancer cells, which may be a 
potential mechanism MSCs utilize to engraft in invasive tumors. Future studies probing 
the engraftment of bone marrow transplanted GFP-labeled MSCs into non-invasive and 
invasive tumors would confirm this hypothesis. These studies would confirm if MSCs are 
recruited to invasive fronts of tumors and could be performed in conjunction with small 
molecule or antibody inhibition of cadherin 11 to confirm this molecule is important  in 
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vivo. Bone marrow-derived cells form premetastatic niches that facilitate metastasis 
[204]. Thus, future studies could be performed to determine if cadherin 11 also facilitates 
the recruitment of tumor cells to premetastatic niches. Cadherin 11 has been shown to be 
upregulated in breast cancer and identified as a therapeutic target [150]. Celecoxib, an 
inhibitor of the inflammatory molecule COX-2, was originally developed as an arthritis 
drug, but has been investigated for the treatment of cancer [205]. Recent studies have 
demonstrated that celecoxib also inhibits cadherin 11 and blocks proliferation of breast, 
prostate, and brain cancer cells [169]. Our studies indicate blocking cadherin 11 may also 
prevent the engraftment of stromal cells, which are known to promote cancer progression 
[28]. In addition, cadherin 11-mediated adhesion occurred in both breast and ovarian 
cancer, suggesting this mechanism of adhesion may be conserved across a number of 
invasive cancers. Our results indicated stromal cells were able to adhere to invasive 
cancer cells that express cadherin 11 and/or 2, which includes most cells that have 
undergone EMT. Thus, celecoxib may be repurposed or other cadherin 11 inhibiting 
drugs or antibodies could be developed to treat a number of different invasive cancers. 
Previously, cadherin 11 inhibition has been investigated for cancers expressing cadherin 
11 [169], but our results indicate this treatment may be effective for a broader range of 
cancers since it blocks stromal cell adhesion with both cadherin 11 and 2 on invasive 
cancer cells. 
 We also elucidated how MSCs induce the invasion of metastatic breast cancer 
cells. MSCs increase the directional migration and force generation of metastatic breast 
cancer cells through TGF-β and downstream mechanosensitive pathways. RTK signaling 
was dispensable for MSC-induced migration. The RTK inhibitor sunitinib in combination 
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with the chemotherapeutic docetaxel was investigated for the treatment of advanced 
breast cancer; however, phase III clinical trial results showed an increase in adverse 
events and no improvement in survival [206]. Consequently, further trials utilizing this 
drug were halted. Our studies indicate that RTK inhibition did not affect breast cancer 
cell directional migration in coculture, which may partly explain why sunitinib failed 
clinically. A number of drugs targeting the TGF-β pathway are currently being 
investigated for pancreatic, colon, brain, and lung cancer [207]. Typically cancer drugs 
are screened for toxicity against tumor cells; however, TGF-β inhibitors primarily target 
the tumor microenvironment and are not cytotoxic to tumor cells making drug screening 
more difficult [207]. Recent studies in colorectal cancer patients revealed a CAF gene 
signature is associated with poor prognosis [35]. CAFs increased the number of tumor-
initiating cells and this effect was enhanced by TGF-β signaling [35]. Inhibiting TGF-β 
halted tumor growth and metastasis in mice [35]. Our results closely matched these 
studies, with TGFβR inhibition blocking MSC-induced directional migration of cancer 
cells. This approach is low-cost and significantly less time consuming compared to in 
vivo studies, suggesting it may be a potential in vitro drug screening tool. Spinning disc 
confocal microscopy in conjunction with image segmentation could also be used to make 
data analysis more automated. The system developed here could also be easily expanded 
to include other types of cells, including immune cells and endothelial cells, to probe 
interactions between tumor cells and the microenvironment. In addition, other ECM 
components and crosslinking agents could be added to probe the effects of matrix 
composition and mechanical properties on tumor cell behavior. This is especially of 
interest for MSC interactions with tumor cells, as MSCs increase traction forces with 
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increasing matrix stiffness [208] and increased contractility is known to activate latent 
TGF-β in the ECM [200]. While we investigated the effect of MSCs on the invasiveness 
of tumor cells, MSCs also have immunomodulatory effects. TGF-β has effects on almost 
all immune cells [207]. TGF-β causes both macrophages and neutrophils to secrete 
inflammatory factors, decreases the activation of B cells, and decreases the proliferation 
of T cells [207]. This indicates that TGF-β secreted in coculture with MSCs may also 
have effects on immune cells. Thus, future studies could utilize coculture studies with 
tumor cells and immune cells to determine how MSCs influence inflammation and tumor 
progression. 
 This work shows how chemical and mechanical cues from microenvironment 
influence the differentiation of MSCs. In addition, we found that MSCs utilize cadherin 
11 to engraft on invasive tumor cells. MSCs induce the directional migration of 
metastatic breast cancer cells through TGF-β and downstream mechanosensitive 
pathways. Together, this work elucidates how the microenvironment influences the 
regenerative and cancer-promoting properties of MSCs. This work has critical 
implications for the design and monitoring of tissue engineered constructs and the 
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